SYSTEMATIC REVIEW article

Front. Endocrinol., 16 June 2022

Sec. Developmental Endocrinology

Volume 13 - 2022 | https://doi.org/10.3389/fendo.2022.840331

Gestational Diabetes Mellitus Among Asians – A Systematic Review From a Population Health Perspective

  • 1. Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  • 2. Department of Medical Statistics and Epidemiology, Sun Yat-sen University, Guangzhou, China

  • 3. School of Public Health, Harvard University, Boston, MA, United States

  • 4. Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH), Bethesda, MD, United States

Abstract

Objective:

Since Asians are particularly vulnerable to the risk of gestational diabetes mellitus (GDM), the lifecourse health implications of which are far beyond pregnancy, we aimed to summarize the literature to understand the research gaps on current GDM research among Asians.

Methods:

We systematically searched the articles in PubMed, Web of Science, Embase, and Scopus by 30 June 2021 with keywords applied on three topics, namely “GDM prevalence in Asians”, “GDM and maternal health outcomes in Asians”, and “GDM and offspring health outcomes in Asians”.

Results:

We observed that Asian women (natives and immigrants) are at the highest risk of developing GDM and subsequent progression to type 2 diabetes among all populations. Children born to GDM-complicated pregnancies had a higher risk of macrosomia and congenital anomalies (i.e. heart, kidney and urinary tract) at birth and greater adiposity later in life.

Conclusion:

This review summarized various determinants underlying the conversion between GDM and long-term health outcomes in Asian women, and it might shed light on efforts to prevent GDM and improve the lifecourse health in Asians from a public health perspective.

Systematic Review Registration:

Prospero, CRD42021286075.

Introduction

Diabetes is a significant cause of morbidity, mortality, and healthcare costs worldwide (1). The global age-adjusted comparative prevalence of diabetes among adults between 20-79 years of age was estimated at 8.3% (463 million) in 2019 (2), including 223 million women living with diabetes. And it is projected to reach 700 million people and 343 million women alone in 2045, respectively (2). Diabetes in pregnancy is similarly increasing in prevalence, with concerning consequences for both mother and offspring (3). Approximately 1 in 6 live births is affected by diabetes in pregnancy, 84% of which are diagnosed as gestational diabetes mellitus (GDM) (2, 4).

GDM is defined as glucose intolerance with the first onset or recognition during pregnancy (2, 4). Women with GDM have higher risks of cardiometabolic disorders during pregnancy and later in life (5). At the same time, offspring born to women with a history of GDM also encounter increased risks of developing obesity and other cardiometabolic disorders later in life (6, 7). The documented prevalence of GDM varies substantially worldwide, ranging from 1% to >30% (3), while compelling evidence has shown Asians share a high prevalence (i.e., Middle East: 8.8-20.0%; South-East Asia: 9.6-18.3%; Western Pacific: 4.5-20.3%) (3) regardless of the racial/ethnic differences in body mass index (BMI).

A meta-analysis found a more than sevenfold increased risk of T2DM in women with GDM after index pregnancy, compared with women with normoglycaemic pregnancies (8). Data on risk factors—particularly modifiable risk factors that may inform effective intervention strategies are relatively more collected in the Western population (e.g., North America, Europe, and Oceania) than the Asian population (3, 8–10). Research reporting a full spectrum of long-term health outcomes among both mothers and offspring following pregnancies complicated by GDM also mainly stemmed from the Western population (11). Furthermore, GDM studies have not been comprehensively reviewed on Asian immigrants exclusively, given that an increasing number of Asian migrants live in Western countries for a long-term residency (12). Due to the different environmental exposures such as socioeconomic transitions, lifestyle adaptations, cultural assimilation hardship, and health disparities9,10, there might be exceptionally high attributable risks on GDM development for Asian immigrants compared with Native Asians.

This review sought to summarize the literature to understand research gaps and develop future research directions on Asian women with GDM from a population health perspective. Thus, our review serves the objectives to 1) comprehensively examine the epidemiology of GDM, its risk factors, and health consequences; and 2) identify areas for future research for public health interventions to prevent GDM and its health consequences.

Methods

Search Strategy and Selection Criteria

We conducted the systematic review according to PRISMA for systematic review protocols. References for this review were identified through searches of Pubmed, Web of Science, Embase, and Scopus for articles published until 30 June 2021. We included three topics in our review, namely “Topic 1—GDM prevalence in Asians”, “Topic 2—GDM and maternal health outcomes in Asians”, and “Topic 3—GDM and offspring health outcomes in Asians”. Search terms included “prevalence”, “incidence”, “gestational diabetes mellitus”, “gestational diabetes” and “diabetes in pregnancy” in combination with the terms “Asia”, “Asians” and “Asian countries” in Topic 1. Search terms included “gestational diabetes mellitus”, “gestational diabetes” and “diabetes in pregnancy” in combination with the terms “Type 2 diabetes”, “prediabetes”, “glucose intolerance”, “abnormal glucose”, “hypertension”, “high blood pressure”, “cardiovascular disease”, “kidney disease”, “cancer”, “liver dysfunction”, “non-alcoholic fatty liver disease” and “health outcomes” and also in combination with the terms “After delivery” and “postpartum” in Topic 2. Search terms included “gestational diabetes mellitus”, “gestational diabetes”, “diabetes in pregnancy” and in combination with terms “cardio-metabolic outcome”, “cognitive outcome”, “congenital disease”, “adiposity”, “hypertension”, “health outcome”, “neuro-cognitive outcome”, “obesity”, “diabetes”, “cardiovascular disease”, “kidney disease” and “cancer” and also in combination with “child” and “offspring” in Topic 3. Articles resulting from these searches and relevant references cited in those articles were reviewed, among which reporting non-Asian human subjects or without full-text available were excluded. Flow charts for literature searching on each topic are shown in Supplementary Figures 1–3. The Prospero registration number for this systematic review is registered as CRD42021286075.

Data Screening & Assessments

Double literature screening was conducted during the literature searching phase by two investigators (H L & L-J L). Furthermore, one investigator (A C) performed the quality assessments for all papers based on the Newcastle–Ottawa Scale Criteria (NOSC), and the other investigators (L-J L) verified the findingsindependently. The maximum score of 9 points in the Newcastle–Ottawa Scale is distributed in three aspects, namely selection of study groups (four points), comparability of groups (two points), and ascertainment of exposure and outcomes (three points) for case–control and cohort studies (13). We used the points to further categorize the publication quality with low risk of bias (between 7-9 points), high risk of bias (between 4-6 points), and very high risk of bias (between 0-3 points) (Supplementary Tables 1, 2).

Results

Prevalence of GDM by Geography

Overview

GDM prevalence in Asian countries ranges widely from 1.2 to 49.5%, largely accounting for differences in diagnostic criteria, sample size and population source (e.g., hospital-based, community-based) (Figure 1 and Supplementary Table 3).

Figure 1

Guideline-Specific Prevalence of GDM

The prevalence of GDM varied substantially across Asian countries using different guidelines (Figure 2). We identified 29 GDM diagnostic criteria (Supplementary Table 4), among which the International Association of Diabetes and Pregnancy Study Groups (IADPSG) (14), World Health Organization (WHO) (15), Carpenter-Coustan (16), and American College of Obstetricians and Gynecologists (ACOG) (17) criteria were commonly used. Some countries adopted international guidelines as their national guidelines [e.g., China MOH guidelines (18), Malaysia MOH guidelines (19)], while some countries defined their own [e.g., Japan [Japan Diabetes Society] (20), India [Diabetes in Pregnancy Study group of India; DIPSI] (21), Turkmenistan (22), Oman (23)]. As the majority (123 out of 147) of included studies were published since 2010, we were not able to tease out whether the increment in GDM prevalence over the years in Asians is due to emerging evidence or new adoption of universal screening [i.e., IADPSG (14)].

Figure 2

We included studies using either one-step or two-step diagnostic guidelines, the latter of which performed a 1-h 50-g glucose challenge test (GCT) glucose challenging test (GCT) additionally during 24-28 weeks of gestation, with a whole blood glucose threshold of 7.2 mmol/l (130 mg/dl). In general, we observed a link between adopting any one-step diagnostic guidelines (e.g., the IADPSG guidelines, the WHO 1999 guidelines) and higher GDM prevalence among Asian studies. For example, countries exclusively using (e.g., Singapore, UAE) or primarily using (e.g., China, Saudi Arabia, India) a one-step diagnostic approach reported an overall GDM prevalence above 10%. In contrast, countries exclusively using (e.g., Pakistan, South Korea) or primarily using (e.g., Thailand, Turkey, Japan) a two-step diagnostic approach reported an overall GDM prevalence below 10% (Figure 3).

Figure 3

Prevalence of GDM in Asian Migrants

Twenty-eight studies reported GDM prevalence among Asian migrants in Europe, Oceania, and North America, with sample sizes ranging from 1,491 to 10,823,924 participants. Overall GDM prevalence among Asian migrants is comparable to the Native Asian population. However, the prevalence of GDM was generally higher in Asian immigrants (0.18%-24.2%) than non-Hispanic White (NHW) (0.02%-7.0%) living in the same country, regardless of GDM diagnostic guidelines used (Supplementary Table 5). Among Asian immigrants in UK and Norway, South, East, and West Asian immigrants, as a whole, had doubled the odds for GDM than NHW (24, 25). Interestingly, length of immigration and birth countries seemed to relate to GDM prevalence. For instance, Danish-Chinese migrants with a longer stay (≥ 10 years) had a 62% higher odds of GDM onset than those with a shorter stay (≤ 5 years) (26). Also, foreign-born US-Indian migrants had a higher GDM prevalence than local-born US-Indian migrants (22.9% vs. 12.8%) (27).

Adverse Health Outcomes and Attributable Risk Factors Following an Index GDM-Complicated pregnancy

Overview

Overall, seventy-two studies, predominantly longitudinal cohorts on GDM and maternal postpartum health outcomes, were identified in Asian countries (Table 1 and Figure 4). Among them, prediabetes and T2D, cardiovascular disorders, cancer, and non-alcoholic fatty liver disease (NAFLD) were reported following index pregnancy complicated by GDM, with a mean or median follow-up from 4 weeks to 38 years after delivery. The majority of studies were reported from East Asia (42/72 studies, 58.3%), especially in the Chinese population. Two studies that reported postpartum T2D development in Asian immigrants were identified (Supplementary Table 6). Thirteen out of 74 included studies (18%) were assessed low in risk of bias, while the rest majority (80%) were either high or very high risk of bias (Supplementary Table 1).

Table 1

Maternal Health OutcomeCountryNoPMIDAuthorYearStudy designMean or range of follow-upNo of GDMNo of outcome cases Cumulative incidence rate; Incidence rate (per 1000 person-years) if applicable*Baseline age, yearsBaseline BMI, kg/m2GDM diagnosis guidelinesOutcome diagnostic guidelines
Pre-diabetes and T2DChina133036614Pei et al.,2021Retrospective cohort study6-12 weeks589Pre-diabetes: 191
T2D: 18
Pre-diabetes: 32.4%
T2D: 3.1%
33-34 (follow-up)21.49-21.99IADPSGWHO 1999
232515856Mao et al.,2020Cross-sectional1.5 year425Pre-diabetes: 62
T2D: 27
Pre-diabetes: 14.6%; 97
T2D: 6.3%; 42
32.3>24: 69.2%
24-27.9: 24.7%
≥28: 6.1%
Did not defineWHO 1999
332080127Miao et al.,2020Prospective cohort5.5 years55Pre-diabetes: 19
T2D: 9
Pre-diabetes: 34.6%; 63
T2D: 16.4%; 30
3122.5NDDG &
IADPSG
WHO 1999
431179619Wang et al.2019Prospective cohort6-12 weeks583Pre-diabetes: 157 T2D: 17Pre-diabetes: 26.9%; N.A.
T2D: 2.9%; N.A.
32.5<25: 78.0%
≥25: 22.0%
Chinese MOHWHO 1998
530999888Liu et al.,2019Prospective cohort6 months91Pre-diabetes: 27
T2D:
Pre-diabetes: 29.7%; N.A.
T2D: 1.1%; N.A.
32.7<18.5: 16.0%
<18.5-24.9: 69.6%
≥25.0: 14.3%
IADPSGWHO 1999
631472162Fan et al.2019Prospective cohort4.22 years1263Pre-diabetes: 457 T2D: 114Pre-diabetes: 36.2%; 86
T2D: 9.0%; 21
32.423.1WHO 1999WHO 1999
730182781Ma et al.,2018Prospective cohort6-8 weeks472Pre-diabetes: 121 T2D: 57Pre-diabetes: 25.6%; N.A.
T2D: 12.1%; N.A.
31.323.1IADPSGWHO 1999
824397392Mai et al.,2014Case-control2.5 years190T2D: 19T2D: 10%; 4033.122.7ADA 2004ADA 2010
925271112Chang et al.,2014Prospective cohort6 weeks ~ ≥ 1 year282T2D: 8T2D: 2.8%; N.A.29.626.2ADA 2007did not define
1018701021Cao et al.,2008Prospective cohort6-8 weeks186Pre-diabetes & T2D: 52Pre-diabetes & T2D: 28.0%; N.A.32.121.9WHO 1999WHO 1999
Taiwan1125865283Lin et al.,2016Retrospective cohort study6 months - 9 years71T2D: 29T2D: 40.8%; N.A.31.724.9NDGGICD
Hong
Kong
1223897066Shek et al.,2014RCT36 months170T2D: 9T2D: 5.3%; 183924.4WHO 1999WHO 1999
1322179684Tam et al.,2012Prospective cohort15 years45Pre-diabetes: 12
T2D: 11
Pre-diabetes: 26.7%; 18
T2D: 24.4%; 16
43.8 (follow-up)24.7
(follow-up)
WHO 1999WHO 1999
1421636867Lee et al.,2011Prospective cohort52 months (4.3 years)238T2D: 47T2D: 19.7%; 4633.924.9 (follow-up)WHO 1998WHO 1998
1510687769Ko et al.,1999Prospective study6 weeks801Pre-diabetes: 182
T2D: 105
Pre-diabetes: 22.7%; N.A.
T2D: 13.1%; N.A.
3424.8Abell and Beischer criteria *WHO 1985
Japan1631969529Kawasaki et al.2020Retrospective cohort study1 year399T2D: 43T2D: 10.8%; N.A.34.123.4JSOG/IADPSGADA 2019
1730239167Kasuga et al.,2019Prospective cohort24.9 weeks213Pre-diabetes: 51
T2D: 8
Pre-diabetes: 23.9%; N.A.
T2D: 3.8%; N.A.
3721.6IADPSGJSOG
1829596944Inoue et al.2018Retrospective cohort study2 years77Pre-diabetes: 17
T2D: 17
Pre-diabetes: 22.1%; 110
T2D: 22.1%; 110
34.323.9IADPSGWHO 1998
1929706019Kondo et al.,2018Retrospective cohort study8-12 weeks123Pre-diabetes: 41
T2D: 4
Pre-diabetes: 33.3%; N.A.
T2D: 3.3%; N.A.
3421.4IADPSGWHO1999
2029310607Kugishima et al.,2018Retrospective cohort study1.09 years306T2D: 32T2D: 10.5%; 963323.5JSOG/IADPSGWHO 1999
2129624902Nishikawa et al.,2018Prospective cohort6-12 weeks185Pre-diabetes: 22
T2D: 3
Pre-diabetes: 11.9%; N.A.
T2D: 1.6%; N.A.
33.0523.15IADPSGADA 2017
2228725256Yasuhi et al.,2017Retrospective cohort study1 year88Pre-diabetes: 29
T2D: 13
Pre-diabetes: 33.0%; N.A.
T2D: 14.8%; N.A.
33.323.9JSOG/IADPSGWHO 2006
2325497883Kugishima et al.,2015Retrospective cohort study6-8 weeks169Pre-diabetes: 52
T2D: 6
Pre-diabetes: 30.8%
T2D: 3.6%
32.623.5JSOG/IADPSGWHO 1999
South Korea2430486265Han et al.,2018Retrospective cohort study10 years4970T2D: 470T2D: 9.5%; 928.321ICD-10ICD-10
2527583868Cho et al.,2016Prospective cohort3.98 years412T2D: 51T2D: 12.4%; 3130.623.5NDGGADA 2010
2627159192Cho et al.,2016Prospective cohort8 years2962T2D: 249T2D; 8.4%; 1129.921.7ICD-10ICD-10
2726996814Kim et al.,2016Prospective cohort6-12 weeks699Pre-diabetes: 343
T2D: 36
Pre-diabetes: 49.1%; N.A.
T2D: 5.2%; N.A.
3322.6CCADA 2014
2826674320Shin et al.,2016Prospective cohort6-12 weeks498Pre-diabetes: 157
T2D: 40
Pre-diabetes: 31.5%; N.A.
TD: 8.0%; N.A.
33.323.7CCADA 2004
2926713061Cho et al.,2015Retrospective cohort study6-12 weeks757Pre-diabetes: 334
T2D: 139
Pre-diabetes: 44.1%; N.A.
T2D: 18.4%; N.A.
33.723.7CCADA 2011
3026171796Moon et al.,2015Prospective cohort4 years283T2D: 48T2D: 17.0%; 423223.3NDGGADA 2010
3124431910Yang et al.,2014Prospective cohort15.6 months (1.3 years)116Pre-diabetes: 59
T2D: 8
Pre-diabetes: 50.9%; 39
T2D; 6.9%; 53
33.823.7 (follow-up)NDGGADA 2011
3223471980Kwak et al.,2013Prospective cohort1 year370T2D: 88T2D: 23.8%; N.A.3223NDGGADA 2014
3324057154Kwak et al.,2013Prospective cohort3.75 years395T2D: 116T2D: 29.4%; 7831.423.2NDGGADA 2013
3421106349Kim et al.,2011Prospective6-12 weeks381Pre-diabetes: 161
T2D: 27
Pre-diabetes: 42.3%; N.A.
T2D: 7.1%; N.A.
34.223.6CCADA 2004
3518456364Lee et al.,2008Prospective cohort2.1 years620T2D: 71T2D: 11.5%; 5533.623.5NDGGICD
3617259506Lim et al.,2007Prospective cohort1 year81Pre-diabetes: 21Pre-diabetes: 25.9%; N.A.34 (follow-up)22.9 (follow-up)NDGGDid not define
3716054264Cho et al.,2006Prospective cohort6 years909Pre-diabetes: 120
T2D: 116
Pre-diabetes: 13.2%; 22
T2D: 12.8%; 21
33.5 (follow-up)24 (follow-up)NDGGNDGG
3812951280Jang et al.,2003Prospective cohort6-8 weeks311Pre-diabetes: 72
T2D: 47
Pre-diabetes: 23.2%; N.A.
T2D: 15.1%; N.A.
30.922.7Korean guidelinesWHO 1985
Pre-diabetes and T2DThailand3929926712Ruksasakul et al.2016Case-control2.97 years56Pre-diabetes: 29Pre-diabetes: 51.8%; 17438.6
(follow-up)
24.6CCADA 2013
4023692133Youngwanichsetha et al.,2013Cross-sectional6 weeks210Pre-diabetes: 56Pre-diabetes: 26.7%; 267
34.518.5-24.9: 23.8%
25-29.9:58.6%
30-39.9:17.6%
(follow-up)
ADA 2010ADA 2011
Malaysia4123268155Chew et al.,2012Cross-sectional study84 months (7 years)342T2D: 53T2D: 15.5%; 2234.727.5 (follow-up)WHO 1985WHO 2002
Singapore4233525398Hewage et al.,2021Prospective cohort1 year116Pre-diabetes: 38
T2D: 13
Pre-diabetes: 32.8%; 38
T2D: 11.2%; 11
33.323.7WHO 1999WHO 1999
Philippines43N/A
Malong et al.,2013Prospective cohort3 years124Pre-diabetes: 43
T2D: 9
Pre-diabetes: 34.7%; 116
T2D: 7.3%; 24
32.123.8IADPSG/CC/WHOADA 2004
India4429802954Goyal et al.,2018Prospective cohort20 months (1.7 years)267Pre-diabetes: 126
T2D: 28
Pre-diabetes: 47.2%; 278
T2D: 10.5%; 62
32.527.3IADPSGADA 2014, WHO 2006
4527329018Bhavadharini et al.,2016Prospective cohort6 weeks -1 year203Pre-diabetes: 34
T2D: 7
Pre-diabetes: 16.7%; N.A.
T2D: 3.4%; N.A.
29.126.9IADPSGADA 2005
4626926329Gupta et al.,2017Prospective cohort14 months (1.2 years)366Pre-diabetes: 144 T2D: 119Pre-diabetes: 39.3%; 328
T2D: 32.5%; 271
30.2<25.0: 67.9%
25.0-29.9: 25.8%
≥ 30.0: 6.3%
IADPSGADA 2014
4725952037Jindal et al.,2015Prospective cohort6 weeks62Pre-diabetes: 17 T2D: 4Pre-diabetes: 27.4%; N.A.
T2D: 6.5%; N.A.
31.5not specifiedADA 2011ADA 2011
4824944938Mahalakshmi et al.,2014Retrospective cohort study4.5 years174T2D: 101T2D: 58.0%; 1292928.6CCWHO 2006
4917640759Krishnaveni et al.,2007Retrospective cohort study5 years35Pre-diabetes: 11
T2D: 13
Pre-diabetes: 31.4%; 63
T2D: 37.1%; 74
28.225.5 (follow-up)WHO 1999WHO 2006
Sri Lanka5029679628Sudasinghe et al.,2018Prospective cohort1 year59Pre-diabetes: 17
T2D: 11
Pre-diabetes: 28.8%; N.A.
T2D: 18.6%; N.A.
<25: 8.9% 25-34: 58.0%
35-49: 33.1%
<18.5: 12.4%
<18.5-24.9: 45.6%
25.0-29.0: 36.1%
≥30: 5.9%
WHO 1999WHO 2006
5128644881Herath et al.,2017Prospective cohort10.9 years119T2D: 73T2D: 61.3%; 5631.7<18.5: 1.5%
18.5-24.9: 57.4%
≥25.0: 41.1%
WHO 1999WHO 1999
5216972862Wijeyaratne et al.,2006Prospective cohort study34.6 months (2.9 years)147Pre-diabetes: 56 T2D: 20Pre-diabetes: 38.1%; 131
T2D: 13.6%; 47
33.426.3WHO 1999IDF
Pakistan5328423981Aziz et al2018Prospective cohort2 years78Pre-diabetes: 3
T2D: 11
Pre-diabetes: 3.8%; 19
T2D: 14.1%; 71
28.9not specifiedIADPSGDid not define
Israel5431167664Yefet et al2019Retrospective cohort study15.8±5.1 years446T2D: 207T2D: 46.4%; 3130.127.0CC and NDDGICD9
5520636958Chodick et al.,2010Retrospective cohort study5.7 years11270T2D: 1125T2D: 10.0%; 18 32.7<25: 14.6%
25-30: 16.7%
>30: 20.0%
unknown 48.6%
NDGGMHS guidelines
Turkey5624591906Kerimoğlu et al.2010Prospective cohort6-12 weeks78Pre-diabetes: 28
T2D: 27
Pre-diabetes: 35.9%; N.A.
T2D: 34.6%; N.A.
31.327.7CCWHO 2006
Iran5728432896Minooee et al.2017Prospective cohort12.1 years476Pre-diabetes: 279
T2D: 49
Pre-diabetes: 58.6%; 48
T2D: 10.3%; 9
36.528.4WHO 1999ADA 1997
5828491872Nouhjah et al.,2017Prospective cohort6-12 weeks176Pre-diabetes: 31
T2D: 8
Pre-diabetes: 17.6%; N.A.
T2D: 4.5%; N.A.
29.727.8IADPSGADA 2003
5925892996Valizadeh et al.,2015Prospective cohort study22.8 months (1.9 years)110Pre-diabetes: 11
T2D: 36
Pre-diabetes: 10%; 53
T2D: 32.7%; 172
>34:64.5%
≤34:35.5%
28.5CCDid not define
6017962102Hossein-Nezhad et al.,2009Retrospective cohort study6-12 weeks114Pre-diabetes: 24
T2D: 9
Pre-diabetes: 21.4%; N.A.
T2D: 8.1%; N.A.
2927.4CCADA/WHO 1985
UAE6115063951Agarwal et al.2004Retrospective cohort study4-8 weeks549Pre-diabetes: 114
T2D: 50
Pre-diabetes: 20.8%; N.A.
T2D: 9.1%; N.A.
32not specifiedADA 1997WHO 1999
Saudi Arabia6230186874Wahabi et al.,2018Prospective cohort1 year133Pre-diabetes: 60
T2D: 15
Pre-diabetes: 45.1%; N.A.
T2D: 11.3%; N.A.
30.427.6WHO 2013ADA 2018
6331435382Mahzari et al.,2018Retrospective cohort study6 weeks123T2D: 82T2D: 66.7%; N.A.3435.6Did not defineDid not define
CancerSouth Korea2430486265Han et al.,2018Retrospective cohort study10 years4970Total cancer: 437
Thyroid Cancer: 131
Total cancer: 8.8%; 9
Thyroid Cancer: 2.6%; 3
28.321ICD-10ICD-10
Taiwan6430796123Peng et al.,2019Retrospective cohort6.84 years47373Total cancer: 1063
Breast cancer: 284
Thyroid cancer: 91
Nasopharynx: 90
Lung and bronchus: 56
Kidney cancer: 25
Total cancer: 2.24%; 3 Breast cancer: 0.6%; 1
Thyroid cancer: 0.2%; 0.3 Nasopharynx: 0.2%; 0.3
Lung and bronchus: 0.1%; 0.2
Kidney cancer: 0.05%; 0.1
29.0not specifiedICD-10ICD-10
Israel6528035489Fuchs et al.2017Retrospective cohort12 years9893Ovary cancer: 9
Uterine cancer: 11
Breast cancer: 91
Ovary cancer: 0.1%; 0.1
Uterine cancer: 0.11%; 0.1
Breast cancer: 0.919%; 1
31.81.1% with maternal obesityMedical recordsMedical records
6621847538Sella et al.2011Retrospective cohort5.19 years11264Digestive organ cancer: 13Digestive organ cancer: 0.11%; 0.230.7220.1% with maternal obesityCCIsrael national cancer registry through linkage data
6717476589Perrin et al.2008Retrospective cohort34 years410Breast cancer: 29Breast cancer: 7.1%; 2<25-35+Not specifiedMedical recordsIsrael national cancer registry ICD-10
6817705823Perrin et al.2007Retrospective cohort38 years410Pancreatic cancer: 5Pancreatic cancer: 1.2%; 0.3<25-35+Not specifiedMedical recordsIsrael national cancer registry ICD-10
Hyperten-sionHong
Kong
1322179684Tam et al.,2012Prospective cohort15 years45Hypertension: 16Hypertension: 35.6%; 2443.8 (follow-up)24.7 (follow-up)WHO 1999WHO 1999
China6928660887Wang et al.,2017Prospective cohort2.29 years1261Hypertension: 94Hypertension: 7.45%; 3332,824.3WHO 19992007 ESH, ESCG
824397392Mai et al.,2014Case-control2.5 years190Hypertension: 10Hypertension: 5.3%; 2133.122.7ADA 2004ADA 2010
DyslipidemiaChina133036614Pei et al.,2021Retrospective cohort study6-12 weeks589Dyslipidaemia: 227Dyslipidaemia: 38.5%33-34 (follow-up)21.49-21.99IADPSGNCEP ATPIII criteria
Metabolic Syndrome (MetS)China7030905596Shen et al.,2019Prospective cohort3.53 years1263Mets NCEP ATPIII criteria: 246
MetS by IDF criteria: 244
Mets by NCEP ATPIII criteria; 19.5%; 55
MetS by IDF criteria: 19.3%; 5473
30.124.2WHO 1999IDF, NCEP ATPIII criteria
824397392Mai et al.,2014Case-control2.5 years190Mets: 38MetS: 20%; 8033.122.7ADA 2004ADA 2010
South Korea2527583868Cho et al.,2016Prospective cohort3.98 years412MetS: 66MetS: 16.0%; 4030.623.5NDGGADA 2010
Thailand3929926712Ruksasakul et al.,2016case control2.97 years56MetS: 1526.8%; 9038.6
(follow-up)
24.6CCAHA/NHLBI criteria
Iran5825892996Valizadeh et al.,2015Prospective cohort22.8 months (1,9 years)110MetS: 2220%; 105>34:64.5% ≤34:35.5%28.5Did not defineIsraelite National Committee Guidelines
Cardiovas-cular (CV) eventsIsrael7123749791Kessous et al.,2013Prospective cohort10 years4928Simple CV events (not specified): 365Simple CV events: 7.4%; 74132.4not specifiedNDGGICD
Non-Alcoholic Fatty Livery Disease (NAFLD)India7232961610Kubihal et al.,2021Cross-sectional16 months (9-38 months)201NAFLD: 126NAFLD: 62.7%; 6331.926.3IADPSGFibroscan

Summary of studies addressing GDM-related maternal health outcomes in Native Asians.

N.A., Not available; T2D, type 2 diabetes; HTN, hypertension; MetS, metabolic syndrome; GDM, gestational diabetes mellitus; BMI, body mass index; AHA, American Heart Association; NHLBI, National Heart Lung and Blood Institutes; ICD, International Classification of Diseases; IDF, International Diabetes Federation; NCEP ATPIII, National Cholesterol Education Program Adult Treatment Panel III; ESH-ESCG, European Society of Hypertension-European Society of Cardiology Guidelines; MHS, Maccabi Healthcare Services; JSOG, Japan Society of Obstetrics and Gynecology; CC, Carpenter-Coustan; ADA, American Diabetes Association; WHO, World Health Organization; NDDG, National Diabetes Data Group; IADPSG, International Association of Diabetes and Pregnancy Study Groups; MOH, Ministry of Health.

Criteria of Abell and Beischer: GDM was defined as if 3hr 50g OGTT of any 2 abnormal glucose readings: 0-hr ≥5.0 mmol/L; 1-hr ≥9.5 mmol/L; 2-hr ≥8.1 mmol/L; 3-hr ≥ 7.0 mmol/L.

Korean guidelines: GDM was defined as if 3hr100g OGTT of any 2 abnormal glucose readings: 0-hr ≥ 5.8 mmol/L; 1-hr ≥10.6 mmol/L; 2-hr ≥ 9.2 mmol/L; 3-hr ≥ 8.1 mmol/L.

Israelite National Committee Guidelines: MetS was defined as having any three of the following traits: waist circumference > 95 cm in females; triglyceride ≥ 150 mg/dL (> 1.70 mmol/L) or drug consumption for elevated triglyceride levels; high-density lipoprotein < 50 mg/dL (< 1.30 mmol/L); systolic blood pressure ≥ 130 and/ or diastolic blood pressure ≥ 85 mm Hg or receiving antihypertensive drugs; and fasting plasma glucose ≥ 100 mg/dL (≥ 5.55 mmol/L) or consuming antiglycemic agents.

IDF: MetS was defined if had central obesity (waist circumference ≥90 cm in men or ≥80 cm in women) plus at least two of the following: (1) raised triglycerides >150 mg/dL (1.7 mmol/ L) or using specific treatment for this lipid abnormality; (2) reduced high-density lipoprotein cholesterol <40 mg/ dL (1.03 mmol/L) in men or <50 mg/dL (1.29 mmol/L) in women or using specific treatment for this lipid abnormality; (3) raised blood pressure (systolic ≥130 mmHg or diastolic ≥85 mmHg or using antihypertensive drugs); and (4) raised fasting plasma glucose >100 mg/dL (5.6 mmol/L) or previously diagnosed type 2 diabetes.

NCEP ATPIII criteria: MetS was defined if had at least three of the following: (1) waist circumference ≥90 cm in men, or ≥80 cm in women; (2) systolic blood pressure ≥130 mmHg, and/or diastolic blood pressure ≥85 mmHg, or using antihypertensive drug treatment; (3) fasting glucose ≥100 mg/dL, or using drug treatment for elevated glucose; (4) triglyceride ≥150 mg/dL or using drug treatment for elevated triglycerides; (5) high-density lipoprotein cholesterol <50 mg/dL in women, or <40 mg/ dL in men, or using drug treatment for reduced high-density lipoprotein cholesterol.

AHA/NHLBI criteria: MetS was defined if 3 out of the following 5 criteria are met, (1) waist circumference>80 cm, (2) blood pressure >130/85 mmHg or on antihypertensive medication, (3) fasting plasma glucose >100 mg/dL or on anti-diabetic medication, (4) fasting triglyceride >150 mg/dL, (5) high-density lipoprotein <50 mg/dL or on antihyperlipidemic medications.

2007 ESH- ESC Guidelines: hypertension was defined as systolic blood pressure ≥ 140mmHg or diastolic blood pressure ≥ 90 mmHg or taking antihypertensive medicines

*Incidence rate in per 100 000 person year is only calculated when the mean year of follow-up is above 1 year.

Figure 4

Prediabetes and T2D

It is well-known that women with a history of GDM have a substantially increased risk of developing T2D than counterparts without such a history (8). A systematic review and meta-analysis on prospective studies with reasonable retention rates (mainly on European women) suggested that the conversion rate from GDM to T2D was seven folds increased among women GDM after index pregnancy, compared with those who had a normoglycaemic pregnancy (RR 7.43, 95% CI: 4.79-11.51) (8).

Sixty-three studies described the postpartum incidence rate of prediabetes and T2D among mothers diagnosed with GDM in Asia, with sample sizes ranging from 35 to 11 270 subjects, most of which defined prediabetes and T2D using the same guidelines [e.g., WHO 1999 (41) or ADA 2014 guidelines (42)] even though their GDM diagnostic criteria differed. We reported the percentage incidence (%) if prediabetes or T2D was recorded within one year from delivery (mostly between 6 and 12 weeks). Then we reported person-years incidence (per 1000 person-years) if prediabetes or T2D was recorded beyond one year from delivery (up to 15 years).

Within one year from delivery, the conversion rate varied significantly between studies from GDM to prediabetes (11.9%-49.1%) and from GDM to T2D (1.1%-66.7%), respectively. Beyond one year after delivery, the incidence rate from GDM to T2D was the highest in South Asia (47 – 271 per 1000 person-years), followed by East Asia (9 – 110 per 1000 person-years). We noted inconsistencies with study estimates within the same region. For instance, one study in Iran reported a much higher incidence T2D conversion rate than another study in Iran (172 vs. 9 per 1000 person-years) (35, 43). Potential reasons for inconsistencies in the conversion rates from GDM to T2D could be the variation in studied population characteristics, duration of follow-up, retention rate, and data collection quality.

As for Asian immigrants, we identified only two reports comparing Asian immigrants with non-Asian counterparts, one from Spain with one-year follow-up (44) and the other from the US with an average 7.6-year follow-up (45). Both studies suggested that prediabetes and T2D conversion rates were higher in South Asian migrants than native NHW [prediabetes: 43.3% vs. 28.5% (44); T2D: 55 vs. 40 per 1000 person-years (45)].

Existing data on risk factors of T2D among women with a history of GDM were firstly reported in the NHW population, such as greater pre-pregnancy BMI (8, 9), excessive weight gain (3), unhealthy dietary patterns (3), physical inactivity (3), and a short period of lactation (3, 10). In the Asian population, there are also quite a few at-risk pre-natal maternal characteristics recently added to this pond of evidence, such as family history of diabetes (43), a higher degree of consanguineous marraiges (43), higher pre-pregnancy BMI (29, 31, 32, 46), higher total cholesterol quartile at GDM diagnosis during the index pregnancy (47), younger age at delivery (<30 years) (46), and a short period of lactation (<6 months) (33). Post-natal risk such as missing medical assistance in the continuum of GDM care after delivery could be another risk for T2D progression among Asian mothers with a history of GDM (48).

Cardiovascular Disorders

Hypertension

A history of GDM was related to increased risk of hypertension (HTN) after the index pregnancy in some but not all studies. For instance, the US Nurses’ Health Study found an increased risk of postpartum HTN among women with a history of GDM (49). In contrast, a Dutch cohort suggested the risk of developing HTN was mainly significant among women with a history of hypertensive disorders during pregnancy (HDP) rather than GDM (50). Among the three studies identified in our review on GDM and subsequent hypertension risk (28, 30, 38), the Chinese Tianjin GDM prevention program reported a much higher incidence rate of HTN among women diagnosed with HDP and GDM than women with GDM alone (118 vs. 26 per 1000 person-years) (38), which partially agreed with the Dutch cohort.

The mechanisms underlying postpartum HTN in women with GDM remain un-elucidated. Insulin resistance may be a component of the underlying pathophysiology linking GDM with postpartum HTN, with or without HDP (51). As we know, obesity and excessive weight gain during pregnancy are associated with insulin resistance (38), inflammation and oxidation (52), all of which may lead to permanent vascular damage (51) and even irreversible peripheral vascular resistance. Due to the largely inadequate evidence, future research to investigate the role of antenatal and postpartum lifestyle (e.g., dietary patterns, physical activities) in the progression of HTN is warranted in Asians.

Cardiovascular Risks and Cardiovascular Diseases

Emerging evidence has led to the increasing recognition of the association between GDM and cardiovascular (CV) risks and CV events later in life (53). Previous studies in the Western population have identified a higher level of inflammatory (e.g., C-reactive protein) (54), vascular endothelial dysfunction (e.g., intimal medial thickness) (55), and a 2-7 times higher risk of coronary artery calcification or CVD after 12-15 years’ follow-up (56–58), among women with a history of GDM. In Asia, five studies reported metabolic syndrome in Asian women with a history of GDM, with an incidence rate ranging from 40 to 90 per 1000 person-years. One Chinese study reported postpartum dyslipidemia (38.5%) among women with a history of GDM (47), while the other Israelite study reported a 30-70% higher risk of developing CV events and CV hospitalization among women with a history of GDM, even after adjusting for pre-eclampsia and maternal obesity at index pregnance (39).

Thus far, only determinants for postpartum CVD risks and CV events were reported as family history of T2D (59) and postpartum development of T2D (58) in the western population. Even though postpartum CVD determinants among women with GDM have yet to be fully investigated, long-standing exposure to cardio-metabolic risks has been speculated in the GDM-CVD link.

Cancer

GDM was associated with 30-40% increased risks of breast cancer, thyroid cancer, stomach cancer, and liver cancer for all races and ethnicities in a recent meta-analysis (60). As in the Asian population alone, we identified six retrospective cohort studies (Taiwan, South Korea and Israel) using either national insurance or a medical database to investigate the association between GDM and various cancers. All of them reported higher incidences of breast cancer, thyroid cancer, pancreatic cancer, ovarian cancer, lung cancer, and kidney cancer among the Asian female population with a history of GDM after a median of 5-38 years of follow-up than those parous women without such a history. For example, the incidence rate of cancer among Israelite women with a history of GDM was reported in breast (2 per 1000 person year) (37) and ovary (1 per 100 person year) (36), respectively.

It has been well documented that T2D is associated with higher risks of all-cancer incidence (61), especially malignancies in the breast, pancreas, and liver in women (62, 63). Some evidence has alluded to the mitogenic effect while binding to the insulin-like growth factor-I receptor secondary to insulin resistance (64). Furthermore, hyperglycemia itself might promote carcinogenesis via increasing oxidative stress (65, 66). However, data regarding cancer risks associated with GDM are merely gathered in the Western population.

Liver Dysfunction

Liver dysfunction is a common cause of chronic liver disease that affects approximately one in four adults worldwide, which is characterized by liver steatosis (fat deposition), inflammation, and hepatocyte damage (67). Researchers have suggested a link between metabolic risks (i.e., obesity, hyperglycemia, hyperlipidemia, and insulin resistance) and hepatic fatty deposition and non-alcoholic fatty liver disease (NAFLD) in the past decades (68, 69). Notably, women with a history of GDM were found to have raised liver triglyceride (TG) levels, highlighting a potential link between GDM and liver dysfunction (70, 71). Despite the higher prevalence of postpartum liver fat (72), abnormal liver score (73) and even NAFLD (71, 74), such results were mostly gathered from the Western population. There is one study from South Asia (India) reported a 2.11-fold higher odds of NAFLD among women with GDM, compared with women without GDM. The researchers suggested that postpartum medical conditions such as overweight/obesity, metabolic syndrome, and prediabetes were risk factors for developing NAFLD, during a median of 16 months’ follow-up after delivery (40).

Adverse Health Outcomes of Offspring Born From Pregnancies Complicated by GDM

Overview

A body of evidence has implied that specific developmental programming in offspring is influenced by maternal hyperglycemia; in particular, epigenetic modification may be the key underlying mechanism (75, 76). Our review identified forty-two studies conducted on Native Asians (Table 2) and eight studies conducted on Asian immigrants (Supplementary Table 7) with up to 18 years’ follow-up, all of which were within the research scope of adverse health outcomes among offspring born to mothers with GDM. Offspring health outcomes, including fetal growth and neonatal anthropometric measures, were reported in Native Asians and Asian migrants, whereas offspring health outcomes, including congenital anomalies, neuro-cognitive function, and cardio-metabolic phenotypes, were only reported in Native Asians (Figure 4). None of these studies investigated risk factors underlying maternal GDM and the development of offspring health outcomes. Among 50 included studies in this topic, fourteen (28%) were assessed low in risk of bias, while the rest 72% were assessed either high or very high in risk of bias.

Table 2

Offspring outcomesCountryNoPMID or DoiAuthorYearStudy designMean or range of follow-upTotal offspring number and outcomes definitionBaseline maternal age,&offspring ageMultiple variable adjustmentEffect size (referencing to non-GDM mothers)
Fetal outcomes
Athropo-metryIndia127913848Venkataraman et al.2016Prospective cohortduring pregnancy153 fetus with GDM mothers,
178 fetus with non-GDM mothers
Mom: 28.6 years
Fetus: 20 wks GA; 28-32 wks GA
Maternal age, BMI, parity, gestational weight gain, fetal sex and gestational ageFetus born to GDM mothers had significantly thicker anterior abdominal wall thickness (20 weeks: 0.26 mm, 0.15-0.37, p<0.0001; 28-32 weeks: 0.48, 0.30-0.65, p<0.0001).
Neonatal outcomes
1. AnthropometryChina233407256Hu et al.2021Prospective cohortat birth205 newborns born to GDM mothers
740 newborns born to non-GDM mothers
Mom: 31.3 years
Offspring: newborn
Age of infants at each measurement, pre-pregnancy BMI, maternal age, parity and gestational ageOffspring born to mothers with GDM had higher weight-for-length z-score (WFLZ) [β: 0.26 SD units (95% CI: 0.13–0.40)] across infancy
than those of mothers without GDM.
329886780Yan et al.2020Prospective cohortat birthMacrosomia: n=630 born to GDM mothers (n=8272); n=2121 for born to non-GDM mothers (n=34085)Mom: 30.5 years
Offspring: newborn
Crude modelInfants born to GDM mothers had lower macrosomia rate (1.5%) while infants born to non-GDM mothers had higher macrosomia rate (4.9%).
431731641Cheng et al.2019Prospective cohortat birthMacrosomia: n=13 born to GDM mothers (n=97); n=51 born to non-GDM mothers (n=853)Mom: did not mention
Offspring: newborn
Maternal age, education, average monthly household income, postpartum BMI, parity, passive smoking, family history of diabetes, iron supplementation, multivitamin supplementation, gestational dietary intake, and alcohol use.Infants born to GDM mother had higher risk of macrosomia (RR: 2.11, 95% CI: 1.16-3.83).
531271809Yang et al.2019Prospective cohortat birthMacrosomia: n=238 born to GDM mothers (n=1495); n=1553 born to non-GDM mothers (n=18127).
LGA: n=240 for GDM mothers (n=1495); n=1486 born to non-GDM mothers (n=18127).
Mom: 28.5 years
Offspring: newborn
Maternal age, family history of diabetes, height, parity, nationality, GA at delivery, child gender, smoking or alcohol use before or during pregnancy, intervention for GDM.Infants born to GDM mothers had higher risk of having macrosomia (OR: 2.70, 95% CI: 2.15-3.40) and LGA (OR: 2.57, 95% CI: 2.05-3.21).
630412096Ding et al.2018Retrospective cohort studyat birthMacrosomia: n=178 born to GDM mothers (n=3221)Mom: 32.7 years
Offspring: newborn
Crude modelBased on the OGTT results, women had three abnormal glucose values had more macrosomia (46/406; 11.3%) than women had two (51/939; 5.4%) or one (81/1876; 4.3%) abnormal glucose values (p<0.001).
727806670Wang et al.2017Retrospective cohort studyat birthMacrosomia: n=447 born to GDM mothers (n=3683); n=7875 born to non-GDM mothers (n=123906)Mom: did not mention
Offspring: newborn
Crude modelInfants born to GDM mothers had an increased risk of macrosomia (OR: 2.42; 95% CI: 2.26-2.59).
826496961Zhao et al.2015Prospective cohort5-10 yearsLGA: n=150 born to GDM mothers (n=1068); n=183 born to non-GDM mothers (n=1756)Mom: 29.8 years
Offspring: newborn
Crude modelGDM mothers had higher rate of LGA infants (14% vs. 10.4%, p=0.005), compared with non-GDM mothers.
926401753Wang et al.2015Prospective cohortat birthMacrosomia: n=49 born to GDM mothers (n=587: 114 obese vs. 473 non-obese); n=33 born to non-GDM mothers (n=478).
LGA: n=182 born to GDM mothers (n=587: 114 obese vs. 473 non-obese); n=136 born to non-GDM mothers (n=478)
Mom: 30.2 years
Offspring: newborn
Maternal age and gestational weeks.No difference in macrosomia and LGA between infants born to GDM and non-GDM mothers.
Infants born to obese GDM mothers had higher macrosomia (p=0.001) and LGA (p<0.001) prevalence than non-obese GDM mothers.
1026376766Chen et al.2015Prospective cohortat birthLGA: n=97 born to GDM mothers (n=1049)Mom: 29 years
Offspring: newborn
Crude modelCompared with normal weight GDM mothers, Infants born to overweight or obese GDM mothers had higher risk of LGA than normal weight GDM mothers (OW: OR 3.8; 95% CI: 2.0–7.0; OB: OR 2.0; 95% CI: 1.2–3.3). Compared with normal GWG mothers with GDM, infants born to GDM mothers with excessive GWG had higher risk of LGA (OR: 3.3; 95% CI: 2.1–5.1).
Bangladesh11http://doi.org/10.3329/jom.v13i2.12749Mannan et al.2012Cross-sectional studyat birthMacrosomia: n=10 born to GDM mothers (n=72); n=2 born to non-GDM mothers (n=72).Mom:
15-25 yrs: 69.5%
26-35 yrs: 23.6%
36-45 yrs: 6.9%
Offspring: newborn
Crude modelNewborn born to mother prior to GDM had a higher macrosomia prevalence (13.9% vs. 2.8), compared with those born to non-GDM mothers.
South Korea129314639Jang et al.1997Case-control studyat birthMacrosomia: n=9 born to GDM mothers (n=65); n=5 born to non-GDM mothers (n=153)
LGA: n=26 born to GDM mothers (n=65); n=20 born to non-GDM mothers (n=153)
Mom: 31.3 years
Offspring: newborn
Crude modelInfants born to GDM mothers had significantly higher rates of macrosomia (13.8% vs. 3.3%) and LGA (40% vs. 13.1%), compared with non-GDM mothers.
Kuwait1330944829Groof et al.2019Cross-sectional studyat birthMacrosomia: n=16 born to GDM mothers (n=109); n=43 born to non-GDM mothers (n=758)Mom: <25 yrs: 16.6%
25-29 yrs: 30.0%
30-34 yrs: 29.4%
≥35 yrs: 24.0%
Offspring: newborn
Maternal nationality, pre-pregnancy BMI, and family history of GDMInfants born to GDM mothers had a higher risk of macrosomia (OR = 2.36; 95% CI: 1.14, 4.89).
Israel1433236556Riskin et al.2020Retrospective cohort studyAt birthLGA: n=50 born to GDM mothers (n=479); n=34 born to non-GDM mothers (n=526).Mean: 33.0 yearsCrude model10.4% of newborns born to GDM mothers had LGA while 6.5% of newborns born to non-GDM mothers had LGA (p<0.001).
1529429374Walter et al.2019Retrospective cohort study18 yearsMacrosomia: n=1318 born to GDM mothers (n=11999); n=9957 born to non-GDM mothers (n=118623)Mom: 30.5 years
Offspring: 18 years
Crude modelInfants born to GDM mothers had higher rates of macrosomia (11.0%).
2. Birth conditionIsrael1433236556Riskin et al.2020Retrospective cohort studyAt birthHypoglycemia: n=34 born to GDM mothers (n=479); n=9 born to non-GDM mothers (n=526).
Polycythemia: n=180 born to GDM mothers (n=479); n=33 born to non-GDM mothers (n=526).
Hypertrophic cardiomyopathy: n=7 born to GDM mothers; none from the non-GDM mothers (n=526).
Mean: 33.0 yearsCrude modelCompared with newborn born to non-GDM mothers, newborn born to GDM mothers had 3.6 odds of hypoglycaemia and 11.1 odds of polycythemia at birth.
Malaysia1631778255Samsuddin et al.2020Prospective cohortat birthHypoglycaemia: n=11 born to GDM mothers (n=145); n=7 born to non-GDM mothers (n=362).Mom: 32.3 years
Offspring: newborn
Crude modelInfants born to GDM mothers had higher rate of hypoglycaemia (9.2% vs. 1.9%), compared with non-GDM mothers.
Saudi Arabia1726409797Alfadhli et al.2015Prospective cohortat birthApgar score <7 at 5 minutes: n=23 born to GDM mothers (n=292); n=3 born to non-GDM mothers (n=281)
Hypoglycaemia: n= 40 born to GDM mothers (n=292); n=4 born to non-GDM mothers (n=281).
Mom: 32.3 years
Offspring: newborn
Crude modelInfants born to GDM mothers had higher risk of neonatal low Apgar score (OR: 5.55; 95% CI: 1.58-19.48) and hypoglycaemia (OR: 9.35; 95%CI: 2.79-31.25).
Thailand1826111427Luengmetta-kul et al.2015Retrospective cohort studyat birthHypoglycaemia: n=25 born to GDM mothers (n=487); n=2 born to non-GDM mothers (n=345).
Hyperbilirubinemia: n=67 born to GDM mothers (n=487); n=27 born to non-GDM mothers (n=345).
Mom: 32.6 years
Offspring: newborn
Crude modelInfants born to GDM mothers had a higher risk of hypoglycaemia (OR: 12.3; P < 0.0001) and neonatal hyperbilirubinemia (OR, 1.9; P = 0.013).
Thailand1924372900Youngwani-chsetha et al.2013Prospective cohortat birthHypoglycaemia: n=50 born to GDM mothers (n=118).Mom: 32.6 years
Offspring: newborn
Crude modelThe incidence of neonatal hypoglycaemia was 42.4% among women with a history of GDM
India2024944938Mahalakshmi et al.2014Retrospective studyat birthHypoglycaemia: n=22 born to GDM mothers (n=174).Mom: 29 years
Offspring: newborn
Crude modelThe incidence of neonatal hypoglycaemia was 12.6% among women with a history of GDM
Bangladesh11http://doi.org/10.3329/jom.v13i2.12749Mannan et al.2012Cross-sectional studyat birthHyperbilirubinemia: n=60 born to GDM mothers (n=72); n=6 born to non-GDM mothers (n=72).
Respiratory distress syndrome: n=8 born to GDM mothers (n=72); n=3 born to non-GDM mothers (n=72).
Mom:
15-25 yrs: 69.5%
26-35 yrs: 23.6%
36-45 yrs: 6.9%
Offspring: newborn
Crude modelMore babies also suffered from neonatal jaundice (22.2% vs 8.4%, p<0.05) and respiratory distress syndrome (11.1% vs 4.17%, p<0.05) in GDM groups than non-GDM groups.
Turkey21322558417Vijay et al.2020Case-controlAt birthVitamin D deficiency (serum values < 20ng/ml): 30 infants born to GDM mothers (n=30); 13 infants born to non-GDM mothers (n=30)Mom: 30 years old.Crude modelThe mean value of Vitamin D levels in GDM babies was 8.47ng/ml and was 19.51ng/ml in the control (p value <0.001).
3. Congenital anomaliesChina630412096Ding et al.2018Retrospective cohort studyat birthFetal malformations (did not specify): n=33 born to GDM mothers (n=3221)Mom: 32.7 years
Offspring: newborn
Crude modelFemale malformation rate born to GDM mothers was 1.02%.
Turkey22DOI:10.5262/tndt.2017.1002.05Soylu et al.2017Case–control study0-18 years21 born to GDM mothers, 259 born to non- GDM mothers
CAKUT: n=14 for GDM newborns; n=126 for non- GDM newborns
Mom: Did not mention
Offspring: CAKUT cases: 6.9 years, Non-CAKUT controls: 5.6 years
Crude modelCAKUT had 10% children born to GDM mothers and the controls only had 5% children born to GDM mothers. However, it is not statistically significant.
Taiwan2326844492Tain et al.2016Case–control studyat birth10543 born to GDM mothers, 1591179 born to non-GDM mothers. Among them:
Congenital anomalies of kidney and urinary tract (CAKUT) : n=11 born to GDM mothers; n=0 born to non-GDM mothers;
Musculoskeletal system anomalies: n=33 born to GDM mothers; n=2753 born to non-GDM mothers;
Eye and face anomalies: n=29 born to GDM mothers; n=2626 born to non-GDM mothers;
Heart and circulatory system anomalies: n=28 born to GDM mothers; n=1623 born to non-GDM mothers;
Genitourinary system: n=20born to GDM mothers; n=1188 born to non-GDM mothers.
Mom: did not mention
Offspring: newborn
Crude modelInfants born to GDM mothers had higher risks of CAKUT (OR 2.22; 95% CI: 1.06-4.67), and also higher prevalence of musculoskeletal system (0.32% vs. 0.17%, p<0.001), eye and face (0.28% vs. 0.17%, p<0.001), heart and circulatory system (0.27% vs. 0.10%, p<0.001) and genitourinary system (0.19% vs. 0.07%, p<0.001), compared those born to non-GDM mothers.
China2426071138Liu et al.2015Retrospective cohort study6 monthsCongenital heart disease: n=206 born to GDM mothers (n=3060); n=17371 born to non-GDM mothers (n=87736).Mom: did not mention
Offspring: 6 months
Crude modelMale infants born to GDM mothers had increased risk of congenital heart disease (OR 2.56; 95% CI: 1.71-3.83).
India2024944938Mahalakshmi et al.2014Retrospective cohort studyat birthCongenital anomalies (did not specify): n=9 born to GDM mothers (n=174)Mom: 29 years
Offspring: newborn
Crude modelCongenital anomalies was 5.2% in GDM mothers.
Bangladesh11http://doi.org/10.3329/jom.v13i2.12749Mannan et al.2012Cross-sectional studyat birthCongenital malformation (did not specify): n=1 born to GDM mothers (n=72); n=2 born to non-GDM mothersMom:
15-25 yrs: 69.5%
26-35 yrs: 23.6%
36-45 yrs: 6.9%
Offspring: newborn
Crude modelThere is no difference between GDM group and non-GDM group regarding congenital malformation.
4. Neuro-Cognitive Structure and FunctionChina2533196602Xuan et al.,2020Case-controlFirst 33-day after delivery31 infants with corrected GA at delivery (33.42-36.00 weeks) born to GDM mother; and 31 GA and sex-matched infants born to non-GDM mothers31.5 years
Offspring: first 33 days postpartum
Crude modelFractional anisotropy was significantly decreased in the splenium of corpus callosum, posterior limb of internal capsule, thalamus in infants born to GDM mothers, reflecting microstructural white matter abnormalities in the GDM group.
Child outcomes
1. Anthro-pometry, Blood pressure, and CV risksChina2633633685Du et al.,2021Prospective cohort1 year old389 infants born to GDM mothers;
778 infants born to non-GDM mothers matched with offspring gender.
Mom: 32.1 years
Offspring: 1 year old
Maternal age, family history of diabetes, parity, gestational weight gain, pre-pregnancy BMI, maternal gestational hypertension, GA, birth weight, birth length, mode of delivery, parental smoking, breastfeeding status, weaning months.Maternal GDM was found to be independently and significantly associated with overweight or obesity in 1-year aged female offspring only
(OR 1.61, 95% CI 1.09–2.37, p < 0.05).
2732861332Liang et al,2020Case-control6 years old560 infants born to GDM mothers; 554 infants born to non-GDM mothers matched with age and sex-frequencyMom: 30.0 years
Offspring: 6 years old
Maternal age at pregnancy, gestational weight gain, gestational age at delivery, numbers of childbirth, smoking status, drinking status, marital status, education, gestational hypertension, occupation of mothers, family history of diabetes, family monthly income treatment of GDM and maternal pre-pregnancy BMI.There is an interaction between maternal BMI genetic risk score (GRS) and GDM status in relation to childhood overweight or obesity.
Per unit of GRS was associated with a 24% (P<.001) and a 28% (P<.001) increased risk of overweight and obesity among children of GDM mothers, whereas no significant associations were observed among children of mothers without GDM.
2830181654Wang et al.2019Prospective cohort1-6 years old1500 born to GDM mothers, 25655 born to non-GDM mothers
N.A.
Mom: 28.5 years
Offspring: each year measured from year 1-year 6
Maternal age and ppBMI, education, smoking status, infant feeding and total GA.Children born to GDM mothers had consistently greater BMI z-score and risk of overweight from year 1 to year 6.
2928120866Zhang et al.2017Cross-sectional study1-5 years1263 born to GDM mothers
Childhood obesity: n=128
Childhood central obesity: n=126
Childhood hyperglycemia: n=126
Mom: 30 years
Offspring: each year from year 1 to year 5
N.A.N.A.
826496961Zhao et al.2015Prospective cohort5-10 yearsChildhood overweight: n=177 born to GDM mothers (n=1068); n=221 born to non-GDM mothers (n=1756).
Childhood obesity: n=114 born to GDM mothers (n=1068); n=210 born to non-GDM mothers (n=1756).
Mom: 29.8 years
Offspring: Year 1-10
Maternal ppBMI, child gender, total GA, infant feeding.At age 1–2 and 2–5 years, no difference in overweight (11.0 v. 12.0%, P=0.917, and 15.7 v. 14.6%, P=0.693, respectively) between children born to GDM and non-GDM mothers.
At age 5–10 years, children born to GDM mothers had higher risk of being overweight and obesity (OR: 2.28, 95% CI 1.61–3.22).
3025716565Chang et al.2015Retrospective cohort study6 years356 born to GDM mothers, 500 born to non-GDM mothers.Mom: 28.6 years
Offspring: 6 years
Crude modelChildren born to GDM mothers had higher BMI (15.8 vs. 12.3, p=0.001), higher sum of skinfold (Subscapular skinfold thickness + Triceps skinfold thickness) (8.2 vs. 4.8cm, p=0.03), compared with those born to non-GDM mothers.
3124689042Liu et al.2014Prospective cohortat 1 year1420 born to GDM mothers, 25737 born to non-GDM mothers.Mom: 29.2 years
Offspring: birth, 3 months, 6 months, 9 months, 12 months
Crude modelInfants born to GDM mothers had bigger change in mean values of z-scores for birth length-for-gestational age (0.16 vs. -0.08), birth weight-for-length (0.30 vs. -0.001), from birth to month 3, and bigger changes in mean value in z-scores from month 9-12 (0.05 vs. 0.02), compared with infants born to non-GDM mothers.
3222160003Andegiorgish et al.2012Cross-sectional studyN.A.Childhood overweight: n=15 born to GDM mothers (n=24); n=518 born to non-GDM mothers (n=1527).Mom: Did not mention
Offspring: 7-11 years & 12-18 years
Paternal obesity and maternal obesity.Children born to GDM mothers had higher rate of overweight (2.8% vs. 0.9%, p=0.003), compared with those born to non-GDM mothers. Children born to GDM mother had a higher risk of overweight (OR: 2.76; 95% CI: 1.11–6.87).
Hong
Kong
3329777227Hui et al.2018Prospective cohortMonth 3-year 16539 born to GDM mothers, 6758 born to non-GDM mothers
N.A.
Mom:
≤24 yrs: 7.3%
25-29 yrs: 27%
30-34 yrs: 40% ≥35 yrs: 26%
Offspring: 3 and 9 months; 2–8 years; 8–16 years
Maternal age and birth place, SES, parental education, presence of PE, maternal smoking and BMI at visit, history of T2D, Child sex, parity and age at visit.Children born to GDM mothers had a lower BMI z-score during infancy (-0.13, 95% confidence interval (CI) -0.22, -0.05) but higher BMI z-scores during childhood (0.14, 95% CI 0.03, 0.25) and adolescence (0.25 95% CI 0.11, 0.38). Breastfeeding for the first three months did not modify the association.
3428279981Tam et al.2017Prospective cohort7 yearsChildhood overweight or obesity (BMI>=85th percentile): n=30 born to GDM mothers (n=123), n=121 born to non-GDM mothers (n=803).
Prediabetes: n=5 born to GDM mothers; n=13 born to non-GDM mothers.
T2D: n=1 born to GDM mothers; n=0 born to non-GDM mothers.
Mom: Did not mention
Offspring: 6.9 years
Crude modelOffspring born to GDM mothers had higher rates of abnormal glucose tolerance (4.7%vs. 1.7%; P = 0.04), higher rates of overweight or obesity, greater BMI, higher blood pressure, lower oral disposition index, and a trend toward reduced b-cell function, compared with those born to mothers without GDM.
3519047239Tam et al.2008Prospective cohort8 years63 born to GDM mothers, 101 born to non-GDM mothersMom: 28.5 years
Offspring: 7.7 years
Child age and gender.Children born to GDM mothers had higher SBP (94 vs 88 mm Hg) and DBP (62 vs 57 mm Hg) and lower HDL (1.58 vs 1.71 mmol/L) levels, compared with those born to non-GDM mothers.
India3625478935Krishnaveni et al.2015Prospective cohort13.5 years26 born to GDM mothers, 208 born to non-GDM mothersMom: Did not mention
Offspring: 13.5 years
Child age, sex, socioeconomic status, and children’s current weight.Children born to GDM mothers had higher insulin level (54.3 vs. 42.5 pmol/L, p=0.02), higher SBP (mean difference: 5.96; 2.10-9.82) and higher insulin resistance (2.0 vs. 1.6, p=0.02) than those born to non-GDM mothers.
Children born to GDM mothers had higher cardia output (0.49, 0.26-0.72), stroke volume 3.98 (2.00, 5.97) and lower total peripheral resistance (-114; -220~-9), compared with those born to non-GDM mothers.
3719918007Krishnaveni et al.2010Retrospective cohort study9.5 years35 born to GDM mothers, 420 born to non-GDM mothers.Mom: Did not mention
Offspring: 9.5 years
Crude modelChildren born to GDM mothers had more adiposity and higher SBP and insulin resistance, compared with control children at age 5 years. And such effects were greater at age 9.5 years.
Israel3821804818Tsadok et al.2011Prospective cohort17 years293 born to GDM mothers, 59499 born to non-GDM mothersMom: 31.2 years
Offspring: 17 years
BirthweightGDM remained significantly associated with offspring 17-year BMI (1.17; 0.81, 1.52) and diastolic BP (1.52; 0.56, 2.48).
Sri Lanka3932670637Herath et al.2020Retrospective cohort study10 yearsOverweight: n= 49 born to GDM mothers (n=159); n=41 born to non-GDM mothers (n=253).
Abdominal obesity: n=24 born to GDM mothers (n=159); n=6 born to non-GDM mothers (n=253).
Mom: 31.9 years
Offspring: 10.9 years
Maternal BMI, maternal age at delivery, and birth order.Children born to GDM mothers had higher median BMI (17.6 vs 16.1, p< 0.001), waist circumference (63 cm vs 59.3 cm, p< 0.001), and triceps skinfold thickness (13.7mm vs 11.2 mm, p< 0.001), and also higher risk of overweight (OR: 2.6, 95% CI 1.4–4.9) and abdominal obesity (OR:2.7, 95% CI 1.1–6.5) at the age of 10-11 years.
Pakistan4030940265Hoodbhoy et al.2018Retrospective cohort study2-5 years53 born to GDM mothers, 83 born to non-GDM mothersMom: 30.8
Offspring: 2-5 years
Crude model
Children born to GDM mothers with medication had a decreased mitral E/A ratio [IQR] = 1.7 [1.6-1.9] and 1.56 [1.4-1.7], respectively, p = 0.02), compared with those born to GDM mothers treated by diet only, and also a higher cIMT (0.48 vs. 0.46, p = 0.03), compared with those born to non-GDM mothers.
There was no significant difference
in offspring cardiac morphology, myocardial systolic and diastolic function, and macrovascular assessment GDM and non-GDM groups.
2.Cognitive functionIndia4120614102Veena et al.2010Prospective cohort9.7 years32 born to GDM mothers, 483 born to non-GDM mothersMom: 26.0 years
Offspring: 9.7 years
Child’s age, sex, gestation, neonatal weight and head circumference, maternal age, parity, BMI, parent’s socio-economic status, education and rural/urban residence.Children born to GDM mothers had significant higher learning, long-term retrieval/storage (β: 0.4SD, 95% CI: 0.01-0.75; p=0.042) and better verbal ability (0.5SD, 0.09-0.83; p=0.015).
3.Endocri-nological and Ophthamo-logical morbidityIsrael1529429374Walter et al.2019Retrospective cohort study18 years11999 born to GDM mothers, 226623 born to non-GDM mothers
Ophthalmic nfection/inflammation: n=89 born to GDM mothers (n=11999); n=1359 born to non-GDM mothers (n=226623).
30.5
18 years old
Crude modelYoung adults born to GDM mothers treated by medication had higher risk of offspring ophthalmic related hospitalization (HR: 1.6, 95% CI: 1.1-2.4) compared with non GDM mothers.
Israel4231117838Shorer et al.2019Retrospective cohort study18 years9312 SGA infants: 259 born to GDM mothers, 9053 born to non-GDM mothers
Among all SGA offspring:
Thyroid disease: n=0 born to GDM mothers; n=8 born to non-GDM mothers.
T1D and T2D: n=0 born to GDM mothers; n=7 born to non-GDM mothers.
Hypoglycemia: n=1 born to GDM mothers; n=18 born to non-GDM mothers.
Childhood obesity: n=1 born to GDM mothers; n=7 born to non-GDM mothers.
Parathyroid hormone disease: n=0 born to GDM mothers; n=3 born to non-GDM mothers.
Adrenal hormone disease: n=0 born to GDM mothers; n=2 born to non-GDM mothers.
Mom: 28.9 years
Offspring: 18 years
Maternal hypertensive disorders, preterm birth, and maternal ageSGA children born to GDM mothers was not associated with higher risk of long-term endocrine morbidity of the offspring (adjusted HR 1.2, 95% confidence interval 0.27–5.00, p=0.82).

Summary of GDM-related offspring health outcomes in Asians.

GDM, gestational diabetes mellitus; DM, diabetes mellitus; HC, head circumference; AC, abdomen circumference; FL, femur length; BPD, biparietal diameter; BMI, body mass index; LGA, large for gestational age; OR, odds ratios; OGTT, oral glucose tolerance test; CAKUT, congenital anomalies of the kidney and urinary tract; SD, standard deviation; HR, hazard ratio; BP, blood pressure; cIMT, carotid intima media thickness.

GDM and Fetal Growth

In-utero over nourishment can lead to fetal overgrowth, and such influence may predispose the offspring to obesity and T2D later in life if there is an obesogenic environment (84). A cohort in India reported an association between GDM and antenatal fetal growth at mid-late trimester (85). In this prospective cohort, fetuses of women with GDM had a thicker anterior abdominal wall while smaller femur length and biparietal diameter than fetuses of women without GDM. The researcher referred to this as “the thin-fat-phenotype” which represented a predisposition to T2D at birth (85).

Among Asian immigrants, one Norwegian study found that fetuses exposed to maternal GDM tended to be smaller in fetal weight at 24 weeks of gestation but thereafter grew faster until delivery, compared with fetuses not exposed to maternal with GDM (86). This trend was more prominent in South Asian women (86).

GDM and Neonatal Outcomes

Anthropometric Outcome At Birth

It is well-accepted that GDM is related to increased risk for macrosomia and large for gestational age (LGA) (6). We identified 14 papers that focused on this topic, with sample sizes ranging from 72 to 11 999 neonates. Among them, the majority reported consistent findings on either higher prevalence rates (11% to 40%) or higher risk ratios (2.0-2.7 times) of macrosomia or LGA among neonates born to GDM mothers, compared with their non-GDM counterparts, despite a couple reported otherwise. Interestingly, one study specifically looked at different combinations of glycemic abnormalities (fasting, 1-hour, and 2-hour glycemic levels) with macrosomia (77). The researchers found that women with three abnormal OGTT glycemic values had a much higher macrosomia rate in their offspring than those with two or one abnormal glycemic value (77). Such results—to some extent—suggested there might be remarkable neonatal outcomes specific to different GDM phenotypes (77).

Four studies reported neonatal birth size in Asian migrants equivocally. The US studies showed no differences in macrosomia rate between neonates born to NHW and Asian women with GDM (87, 88). In contrast, compared with the NHW counterparts, the Dutch study showed a lower macrosomia rate in offspring born to West Asian migrants (Turkish) (89) (18.6% vs. 22.6% [NHW]), while the Canadian study found that newborns born to South Asian female migrants had a greater skinfold thickness (11.7 vs 10.6 mm [NHW]; p=0.0001) (90).

Neonatal Health Ouctomes

Eight papers reporting other neonatal conditions were identified in our review, ranging from 72 to 10 543 in sample size. Neonatal disorders were listed as hypoglycemia, low Apgar score, hyperbilirubinemia/jaundice, polycythemia and respiratory distress syndrome. All studies consistently reported that neonates born to women with GDM were more susceptible to hypoglycemia, hyperbilirubinemia, respiratory distress syndrome and low Apgar score (<7 at 5 minutes), compared with those born to women without GDM.

Congenital Diseases

A total number of six studies reported findings on this topic, only half of which had specified the type of malformation as either congenital heart disease or congenital anomalies of the kidney and urinary tract (CAKUT). In general, evidence showed that neonates born to mothers with GDM tended to have a 2-3 times higher risk of developing congenital heart disease and CAKUT, especially more evident in male neonates (79). Despite the unclear pathophysiological mechanism, it has been speculated that serial maternal antenatal characteristics could affect embryonic development during the first trimester, such as pre-existing diabetes prior to pregnancy, overweight and obesity, and excessive weight gain during pregnancy (79, 91, 92).

Neuro-Cognitive Structure and Function

There is one case-control study investigated brain function in pre-term infants born to mother with GDM. In the first 33 days after delivery, the researchers used MRI image and discovered that infants born to mother with GDM tended to have multiple reduced fractional anisotropy in the brain, reflecting a microstructural white matter abnormalities compared with the infants born to mother without GDM (80).

GDM and Childhood Outcomes

Twenty studies on this topic were identified, with nearly half reported in China (n=8), then followed by India (n=4), Israel (n=3), Hong Kong (n=3), Pakistan (n=1), and Sri Lanka (n=1). Childhood outcomes spanned several traits and conditions, including adiposity and cadiometabolic outcomes, cognitive function, endocrinological and ophthalmological morbidity.

Anthropometry, Blood Pressure and Cardiometaboilc Outcomes

The majority of studies (17/20, 85.0%) reported consistent findings on long-term outcomes like childhood adiposity and cardio-metabolic risks. Overall, offspring born to women with GDM had higher BMI z-score, higher systolic blood pressure and diastolic blood pressure, higher childhood overweight and obesity rates, higher lipid profile levels, and higher insulin and insulin resistance levels, than those born to women without GDM. These studies involved small (n=164) to large (n=27 157) sample sizes of offspring with an average follow-up of 1-18 years among different ethnicities (Chinese, Indians, Sri Lankans and Israelite Jews).

In terms of cardiac function, we included one Pakistani study (93) and one Indian study (81) with small sample sizes of 136 and 236. Compared with their counterparts, offspring born to women with GDM had higher Carotid Intima-Media Thickness (cIMT), cardiac output and stroke volume, decreased mitral E/A ratio, and total peripheral resistance in early childhood and early adolescence, respectively.

Among Asian immigrants, two studies in the UK (94, 95) and one study in the US (96) with sample sizes ranging from 382 to 6 060 reported a consistent association between GDM and childhood obesity across all races and ethnic groups. The magnitude in such association between NHW women and Asian female immigrants was similar.

Neuro-Cognitive Outcomes

Hyperglycemia during pregnancy may affect fetal neurodevelopment and leave a significant impact on offspring cognition (97). Only one Indian study reported neurocognitive outcomes in the offspring at a mean 9.7 years of age (82). Children born to women with GDM had higher learning, long-term retrieval and storage, and better verbal ability than children born to women without GDM. The authors propose that the finding may be confounded by the strong correlation between GDM and higher social-economic status among this cohort (82).

Endocrinological and Ophthalmological Outcomes

Other childhood outcomes related to GDM include endocrine and ophthalmic morbidities. In two large-scale Israelite cohort studies where young adults (≤ 18 years) with a history of small-than-gestational age (SGA) conditions were recruited. One study showed no difference in the incidence of endocrine morbidity between young adults born to women with and without GDM (83). In contrast, the other study observed a higher prevalence of offspring ophthalmic inflammation (0.74% vs. 0.60%) and a 60% higher risk in ophthalmic-related hospitalization among young adults born to women with GDM and treated with medication (metformin, insulin) (78).

Discussion and Future Direction

Our review reinforces that, in general, Asians are at the highest risk of developing GDM and for subsequent progression to T2D among all populations. Yet, data among the Asian population on long-term health implications of GDM on women and offspring remain limited and are less in-depth than the Western population. In addition, studies in identifying attributable risk factors that may inform preventive strategies of long-term adverse health outcomes among women and their offspring are less comprehensive in Asians than in the Western population. Methodologically, inferences from existing published data are hindered by considerable heterogeneity in study designs, a high risk of bias (Supplementary Tables 1, 2), and standardized protocols for defining studies of Asians.

In order to address such critical knowledge gaps, future endeavors in the following aspects may be warranted to dissect the vicious circle of “diabetes begetting diabetes” and improve the health and well-being of this and future generations.

1. Conducting large scale well-designed cohort studies and/or consortium networks among Asians to investigate risk factors and etiology of GDM. A better understanding of GDM pathogenesis specific to Asian women shall further enhance our knowledge on the unique GDM characteristics among Asian women and develop more targeted and effective intervention approaches to prevent GDM and interrupt the transgenerational diabetic vicious cycle. However, such GDM heterogeneity-specific maternal health outcomes in Asians are still limited in scope, let alone other elements of the potential impact such as genetic factors and fetal sex. Future endeavors to establish parallel prospective pregnancy cohorts—with longitudinal data collection and comprehensive characterization of metabolic profiles through pregnancy in different Asian regions—are warranted to understand biological differences across Asian ethnicities, identify determinants and even develop prediction models for GDM onset and its phenotype-specific transgenerational health outcomes.

2. Conducting prospective cohort studies and/or intervention studies to follow up both GDM women and their offspring following the index pregnancy to identify factors that may mitigate the adverse impact of GDM on both women and their children. With the increasing awareness of the GDM burden and subsequent adverse health outcomes in Asian women and their offspring, a few large-scale ongoing pre-conception and pregnancy trials have focused on lifestyle intervention in Asia, such as Project SARAS in Mumbai (98) and the VINAVAC study in Vietnam (99). However, inferences from these two trials are inconsistent, which might be hindered by participants’ low compliance, including low uptake rate of OGTT, poor quality of data collection (e.g., physical examination, questionnaires administration) during research visits, and not quantitative constituents in the snack or freshly-prepared food given to the intervention group (98, 99). In terms of postpartum trials, substantial evidence in either lifestyle modifications (100) or pharmacological therapies (101–103) gathered from developed countries has shown promising results. However, intervention studies with customized approaches (e.g., diet recommendation, lifestyle modification) according to the Asian population are much fewer in scope than the Western population. Recently, there have been some improvements, including a few postpartum T2D prevention trials conducted in countries like China (100, 104), Singapore (105), Malaysia (106), and India (107), focusing on lifestyle modification, with a sample range between 77 and 1 414 and a length of follow-up up to 10 years. However, most of them are still ongoing, and only two trials reported more significant weight loss, reduction in waist circumference, and improved glucose tolerance during the 6-12 months’ postpartum period (104, 106).

3. Conducting studies of Health Disparities in GDM Care in Asian Populations across countries and continents. Even though developing countries in Asia (e.g., India) have shown increased life expectancy over the past several decades, health inequity is still a severe national issue as progress is uneven within each country (108). Furthermore, not all but a substantial proportion of Asian migrants in Western countries face socio-economical disadvantages such as access to health care and education (109). Among them, women seem to be more affected than men due to their vulnerability (109). Therefore, the fight against GDM and its harm to Asian mothers and children should account for existing health inequity and develop strategies to address health disparities.

4. Health Care System Improvement in Asia. Emerging evidence has pointed out that a portion of GDM cases was indeed overt diabetes that has not been identified before pregnancy, which ultimately drives the risk of maternal and offspring health outcomes even higher (110). For example, collecting information on pre-existing maternal diabetes or overt diabetes identification during early pregnancy in the Asian health care system is critical to screen for and even prevent offspring congenital abnormality or other adverse fetal and neonatal health outcomes. Ideally, GDM rates in the population could be reduced by individual and societal measures designed to promote healthy lifestyle changes, including optimal dietary intake and increased physical activity in the general population, focusing on the health and fitness of women of reproductive age.

Funding

L-JL is funded by Singapore National Medical Research Council Clinician Science Award 2021 (NMRC CSAINV/002/2021).

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding authors.

Author contributions

L-JL contributed to the review’s framework conceptualization, study, design, literature research, data collection, analysis and interpretation, and manuscript write-up; LH contributed to literature search, data collection and summary; DT contributed to data interpretation and manuscript editing; CZ contributed to the review’s framework conceptualization, study design, data interpretation and manuscript editing. All authors contributed to the article and approved the submitted version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fendo.2022.840331/full#supplementary-material

Supplementary Figure 1

Flow diagram of search strategy and selection of GDM prevalence in the Asian population including Native Asians and Asian migrants.

Supplementary Figure 2

Flow diagram of search strategy and selection of GDM-related maternal postpartum health outcomes in the Asian population including Native Asians and Asian migrants.

Supplementary Figure 3

Flow diagram of search strategy and selection of GDM-related offspring postpartum health outcomes in the Asian population including Native Asians and Asian migrants.

References

  • 1

    Collaboration NCDRF. Worldwide Trends in Diabetes Since 1980: A Pooled Analysis of 751 Population-Based Studies With 4.4 million participants. Lancet (2016) 387(10027):1513–30. doi: 10.1016/S0140-6736(16)00618-8

  • 2

    International Diabetes Federation. IDF Diabetes ATLAS 9th Edition 2019 (2019). Available at: https://wwwidforg/our-activities/care-prevention/gdm.

  • 3

    McIntyreHDCatalanoPZhangCDesoyeGMathiesenERDammP. Gestational Diabetes Mellitus. Nat Rev Dis Primers (2019) 5(1):47. doi: 10.1038/s41572-019-0098-8

  • 4

    ChoNHShawJEKarurangaSHuangYda Rocha FernandesJDOhlroggeAWet al. IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045. Diabetes Res Clin Pract (2018) 138:271–81. doi: 10.1016/j.diabres.2018.02.023

  • 5

    YogevYXenakisEMLangerO. The Association Between Preeclampsia and the Severity of Gestational Diabetes: The Impact of Glycemic Control. Am J Obstet Gynecol (2004) 191(5):1655–60. doi: 10.1016/j.ajog.2004.03.074

  • 6

    Group HSCRMetzgerBELoweLPDyerARTrimbleERChaovarindrUet al. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med (2008) 358(19):1991–2002. doi: 10.1056/NEJMoa0707943

  • 7

    ClausenTDMathiesenERHansenTPedersenOJensenDMLauenborgJet al. High Prevalence of Type 2 Diabetes and Pre-Diabetes in Adult Offspring of Women With Gestational Diabetes Mellitus or Type 1 Diabetes: The Role of Intrauterine Hyperglycemia. Diabetes Care (2008) 31(2):340–6. doi: 10.2337/dc07-1596

  • 8

    BellamyLCasasJPHingoraniADWilliamsD. Type 2 Diabetes Mellitus After Gestational Diabetes: A Systematic Review and Meta-Analysis. Lancet (2009) 373(9677):1773–9. doi: 10.1016/S0140-6736(09)60731-5

  • 9

    BaoWYeungETobiasDKHuFBVaagAAChavarroJEet al. Long-Term Risk of Type 2 Diabetes Mellitus in Relation to BMI and Weight Change Among Women With a History of Gestational Diabetes Mellitus: A Prospective Cohort Study. Diabetologia (2015) 58(6):1212–9. doi: 10.1007/s00125-015-3537-4

  • 10

    LeySHChavarroJELiMBaoWHinkleSNWanderPLet al. Lactation Duration and Long-Term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus. Diabetes Care (2020) 43(4):793–8. doi: 10.2337/dc19-2237

  • 11

    EyalS. Gestational Diabetes Mellitus: Long-Term Consequences for the Mother and Child Grand Challenge: How to Move on Towards Secondary Prevention? Front Clin Diabetes Healthc (2020) 1(546256). doi: 10.3389/fcdhc.2020.546256

  • 12

    World Migration Report 2020 (2020). Available at: https://publicationsiomint/system/files/pdf/wmr_2020pdf (Accessed on 24 Aug 2021).

  • 13

    Wells BSGAO'ConnellDPetersonJWelchVLososMTugwellP. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses . Available at: http://wwwohrica/programs/clinical_epidemiology/oxfordasp (Accessed on 2 Nov 2021. 2013).

  • 14

    International Association of D, Pregnancy Study Groups Consensus PMetzgerBEGabbeSGPerssonBBuchananTACatalanoPAet al. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care (2010) 33(3):676–82. doi: 10.2337/dc09-1848

  • 15

    Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications : Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization (1999).

  • 16

    CarpenterMWCoustanDR. Criteria for Screening Tests for Gestational Diabetes. Am J Obstet Gynecol (1982) 144(7):768–73. doi: 10.1016/0002-9378(82)90349-0

  • 17

    Committee Opinion No. 504: Screening and Diagnosis of Gestational Diabetes Mellitus. Obstet Gynecol (2011) 118(3):751–3. doi: 10.1097/AOG.0b013e3182310cc3

  • 18

    YangHX. Diagnostic Criteria for Gestational Diabetes Mellitus (WS 331-2011). Chin Med J (Engl) (2012) 125(7):1212–3. doi: 10.2337/dc10-0572

  • 19

    Malaysia MoH. Perinatal Care Manual 3rd Edition. Putrajaya, Malaysia: Division of Family Health Development, MOH (2013). p. 251.

  • 20

    KuzuyaTNakagawaSSatohJKanazawaYIwamotoYKobayashiMet al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Diabetes Res Clin Pract (2002) 55(1):65–85. doi: 10.1016/S0168-8227(01)00365-5

  • 21

    SeshiahVDasAKBalajiVJoshiSRParikhMNGuptaSet al. Gestational Diabetes Mellitus–Guidelines. J Assoc Physicians India (2006) 54:622–8.

  • 22

    ParhoferKGHasbargenUUlugberdiyewaAAbdullayewaMMelebayewaBAnnamuhammedovAet al. Gestational Diabetes in Turkmenistan: Implementation of a Screening Program and First Results. Arch Gynecol Obstet (2014) 289(2):293–8. doi: 10.1007/s00404-013-2961-2

  • 23

    Abu-HeijaATAl-BashMMathewM. Gestational and Pregestational Diabetes Mellitus in Omani Women: Comparison of Obstetric and Perinatal Outcomes. Sultan Qaboos Univ Med J (2015) 15(4):e496–500. doi: 10.18295/squmj.2015.15.04.009

  • 24

    KhalilARezendeJAkolekarRSyngelakiANicolaidesKH. Maternal Racial Origin and Adverse Pregnancy Outcome: A Cohort Study. Ultrasound Obstet Gynecol (2013) 41(3):278–85. doi: 10.1002/uog.12313

  • 25

    JenumAKMorkridKSletnerLVangenSTorperJLNakstadBet al. Impact of Ethnicity on Gestational Diabetes Identified With the WHO and the Modified International Association of Diabetes and Pregnancy Study Groups Criteria: A Population-Based Cohort Study. Eur J Endocrinol (2012) 166(2):317–24. doi: 10.1530/EJE-11-0866

  • 26

    Kragelund NielsenKAndersenGSDammPAndersenAN. Gestational Diabetes Risk in Migrants. A Nationwide, Register-Based Study of All Births in Denmark 2004 to 2015. J Clin Endocrinol Metab (2020) 105(3). doi: 10.1210/clinem/dgaa024

  • 27

    JanevicTZeitlinJEgorovaNBalbierzAHowellEA. The Role of Obesity in the Risk of Gestational Diabetes Among Immigrant and U.S.-Born Women in New York City. Ann Epidemiol (2018) 28(4):242–8. doi: 10.1016/j.annepidem.2018.02.006

  • 28

    MaiCWangBWenJLinXNiuJ. Lipoprotein-Associated Phospholipase A2 and AGEs Are Associated With Cardiovascular Risk Factors in Women With History of Gestational Diabetes Mellitus. Gynecol Endocrinol (2014) 30(3):241–4. doi: 10.3109/09513590.2013.871522

  • 29

    ShekNWNgaiCSLeeCPChanJYLaoTT. Lifestyle Modifications in the Development of Diabetes Mellitus and Metabolic Syndrome in Chinese Women Who Had Gestational Diabetes Mellitus: A Randomized Interventional Trial. Arch Gynecol Obstet (2014) 289(2):319–27. doi: 10.1007/s00404-013-2971-0

  • 30

    TamWHMaRCYangXKoGTLaoTTChanMHet al. Cardiometabolic Risk in Chinese Women With Prior Gestational Diabetes: A 15-Year Follow-Up Study. Gynecol Obstet Invest (2012) 73(2):168–76. doi: 10.1159/000329339

  • 31

    KondoMNagaoYMahbubMHTanabeTTanizawaY. Factors Predicting Early Postpartum Glucose Intolerance in Japanese Women With Gestational Diabetes Mellitus: Decision-Curve Analysis. Diabetes Med (2018) 35(8):1111–7. doi: 10.1111/dme.13657

  • 32

    KugishimaYYasuhiIYamashitaHFukudaMKuzumeASugimiSet al. Risk Factors Associated With Abnormal Glucose Tolerance in the Early Postpartum Period Among Japanese Women With Gestational Diabetes. Int J Gynaecol Obstet (2015) 129(1):42–5. doi: 10.1016/j.ijgo.2014.09.030

  • 33

    HewageSSKohXYHSohSEPangWWFokDCaiSet al. Breastfeeding Duration and Development of Dysglycemia in Women Who Had Gestational Diabetes Mellitus: Evidence From the GUSTO Cohort Study. Nutrients (2021) 13(2):408. doi: 10.3390/nu13020408

  • 34

    MalongCLSia-AtanacioAAndag-SilvaACunananE. Incidence of Postpartum Diabetes and Glucose Intolerance Among Filipino Patients With Gestational Diabetes Mellitus Seen at a Tertiary Hospital. J ASEAN Fed Endocr Soc (2013) 28(1):56

  • 35

    ValizadehMAlaviNMazloomzadehSPiriZAmirmoghadamiH. The Risk Factors and Incidence of Type 2 Diabetes Mellitus and Metabolic Syndrome in Women With Previous Gestational Diabetes. Int J Endocrinol Metab (2015) 13(2):e21696. doi: 10.5812/ijem.21696

  • 36

    FuchsOSheinerEMeirovitzMDavidsonESergienkoRKessousR. The Association Between a History of Gestational Diabetes Mellitus and Future Risk for Female Malignancies. Arch Gynecol Obstet (2017) 295(3):731–6. doi: 10.1007/s00404-016-4275-7

  • 37

    PerrinMCTerryMBKleinhausKDeutschLYanetzRTiramEet al. Gestational Diabetes and the Risk of Breast Cancer Among Women in the Jerusalem Perinatal Study. Breast Cancer Res Treat (2008) 108(1):129–35. doi: 10.1007/s10549-007-9585-9

  • 38

    WangLLengJLiuHZhangSWangJLiWet al. Association Between Hypertensive Disorders of Pregnancy and the Risk of Postpartum Hypertension: A Cohort Study in Women With Gestational Diabetes. J Hum Hypertens (2017) 31(11):725–30. doi: 10.1038/jhh.2017.46

  • 39

    KessousRShoham-VardiIParienteGSherfMSheinerE. An Association Between Gestational Diabetes Mellitus and Long-Term Maternal Cardiovascular Morbidity. Heart (2013) 99(15):1118–21. doi: 10.1136/heartjnl-2013-303945

  • 40

    KubihalSGuptaYShalimarKandasamyDGoyalAKalaivaniMet al. Prevalence of Non-Alcoholic Fatty Liver Disease and Factors Associated With it in Indian Women With a History of Gestational Diabetes Mellitus. J Diabetes Investig (2021) 12(5):877–85. doi: 10.1111/jdi.13411

  • 41

    World Health Organization. Definition DaCoDMaiCRoaWC. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Org (1999). Available at: https://appswhoint/iris/bitstream/handle/10665/66040/WHO_NCD_NCS_992pdf?sequence=1&isAllowed=y.

  • 42

    American DiabetesA. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (2014) 37 Suppl 1:S81–90. doi: 10.2337/dc14-S081

  • 43

    MinooeeSRamezani TehraniFRahmatiMMansourniaMAAziziF. Diabetes Incidence and Influencing Factors in Women With and Without Gestational Diabetes Mellitus: A 15year Population-Based Follow-Up Cohort Study. Diabetes Res Clin Pract (2017) 128:24–31. doi: 10.1016/j.diabres.2017.04.003

  • 44

    PradosMFlores-Le RouxJABenaigesDLlauradoGChillaronJJPayaAet al. Gestational Diabetes Mellitus in a Multiethnic Population in Spain: Incidence and Factors Associated to Impaired Glucose Tolerance One Year After Delivery. Endocrinol Diabetes Nutr (2019) 66(4):240–6. doi: 10.1016/j.endinu.2018.07.007

  • 45

    MukerjiGChiuMShahBR. Impact of Gestational Diabetes on the Risk of Diabetes Following Pregnancy Among Chinese and South Asian Women. Diabetologia (2012) 55(8):2148–53. doi: 10.1007/s00125-012-2549-6

  • 46

    ShenYWangPWangLZhangSLiuHLiWet al. Gestational Diabetes With Diabetes and Prediabetes Risks: A Large Observational Study. Eur J Endocrinol (2018) 179(1):51–8. doi: 10.1530/EJE-18-0130

  • 47

    PeiLXiaoHLaiFLiZLiZYueSet al. Early Postpartum Dyslipidemia and Its Potential Predictors During Pregnancy in Women With a History of Gestational Diabetes Mellitus. Lipids Health Dis (2020) 19(1):220. doi: 10.1186/s12944-020-01398-1

  • 48

    GirgisCMGuntonJECheungNW. The Influence of Ethnicity on the Development of Type 2 Diabetes Mellitus in Women With Gestational Diabetes: A Prospective Study and Review of the Literature. ISRN Endocrinol (2012) 2012:341638. doi: 10.5402/2012/341638

  • 49

    TobiasDKHuFBFormanJPChavarroJZhangC. Increased Risk of Hypertension After Gestational Diabetes Mellitus: Findings From a Large Prospective Cohort Study. Diabetes Care (2011) 34(7):1582–4. doi: 10.2337/dc11-0268

  • 50

    HeidaKYFranxAvan RijnBBEijkemansMJBoerJMVerschurenMWet al. Earlier Age of Onset of Chronic Hypertension and Type 2 Diabetes Mellitus After a Hypertensive Disorder of Pregnancy or Gestational Diabetes Mellitus. Hypertension (2015) 66(6):1116–22. doi: 10.1161/HYPERTENSIONAHA.115.06005

  • 51

    CarpenterMW. Gestational Diabetes, Pregnancy Hypertension, and Late Vascular Disease. Diabetes Care (2007) 30 Suppl 2:S246–50. doi: 10.2337/dc07-s224

  • 52

    LiLJIkramMKCheungCYLeeYSLeeLJGluckmanPet al. Effect of Maternal Body Mass Index on the Retinal Microvasculature in Pregnancy. Obstet Gynecol (2012) 120(3):627–35. doi: 10.1097/AOG.0b013e3182639577

  • 53

    BurlinaSDalfraMGChilelliNCLapollaA. Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update. Int J Endocrinol (2016) 2016:2070926. doi: 10.1155/2016/2070926

  • 54

    Di CianniGLencioniCVolpeLGhioACuccuruIPellegriniGet al. C-Reactive Protein and Metabolic Syndrome in Women With Previous Gestational Diabetes. Diabetes Metab Res Rev (2007) 23(2):135–40. doi: 10.1002/dmrr.661

  • 55

    BoSValpredaSMenatoGBardelliCBottoCGambinoRet al. Should We Consider Gestational Diabetes a Vascular Risk Factor? Atherosclerosis (2007) 194(2):e72–9. doi: 10.1016/j.atherosclerosis.2006.09.017

  • 56

    TobiasDKStuartJJLiSChavarroJRimmEBRich-EdwardsJet al. Association of History of Gestational Diabetes With Long-Term Cardiovascular Disease Risk in a Large Prospective Cohort of US Women. JAMA Intern Med (2017) 177(12):1735–42. doi: 10.1001/jamainternmed.2017.2790

  • 57

    BellamyLCasasJPHingoraniADWilliamsDJ. Pre-Eclampsia and Risk of Cardiovascular Disease and Cancer in Later Life: Systematic Review and Meta-Analysis. BMJ (2007) 335(7627):974. doi: 10.1136/bmj.39335.385301.BE

  • 58

    ShahBRRetnakaranRBoothGL. Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus. Diabetes Care (2008) 31(8):1668–9. doi: 10.2337/dc08-0706

  • 59

    CarrDBUtzschneiderKMHullRLTongJWallaceTMKodamaKet al. Gestational Diabetes Mellitus Increases the Risk of Cardiovascular Disease in Women With a Family History of Type 2 Diabetes. Diabetes Care (2006) 29(9):2078–83. doi: 10.2337/dc05-2482

  • 60

    WangYYanPFuTYuanJYangGLiuYet al. The Association Between Gestational Diabetes Mellitus and Cancer in Women: A Systematic Review and Meta-Analysis of Observational Studies. Diabetes Metab (2020) 46(6):461–71. doi: 10.1016/j.diabet.2020.02.003

  • 61

    NotoHTsujimotoTSasazukiTNodaM. Significantly Increased Risk of Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis. Endocr Pract (2011) 17(4):616–28. doi: 10.4158/EP10357.RA

  • 62

    WolfISadetzkiSCataneRKarasikAKaufmanB. Diabetes Mellitus and Breast Cancer. Lancet Oncol (2005) 6(2):103–11. doi: 10.1016/S1470-2045(05)01736-5

  • 63

    ZhouXHQiaoQZetheliusBPyoralaKSoderbergSPajakAet al. Diabetes, Prediabetes and Cancer Mortality. Diabetologia (2010) 53(9):1867–76. doi: 10.1007/s00125-010-1796-7

  • 64

    SciaccaLCassarinoMFGenuaMPandiniGLe MoliRSquatritoSet al. Insulin Analogues Differently Activate Insulin Receptor Isoforms and Post-Receptor Signalling. Diabetologia (2010) 53(8):1743–53. doi: 10.1007/s00125-010-1760-6

  • 65

    JeeSHOhrrHSullJWYunJEJiMSametJM. Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women. JAMA (2005) 293(2):194–202. doi: 10.1001/jama.293.2.194

  • 66

    StocksTRappKBjorgeTManjerJUlmerHSelmerRet al. Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-can): Analysis of Six Prospective Cohorts. PloS Med (2009) 6(12):e1000201. doi: 10.1371/journal.pmed.1000201

  • 67

    YounossiZMKoenigABAbdelatifDFazelYHenryLWymerM. Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology (2016) 64(1):73–84. doi: 10.1002/hep.28431

  • 68

    FraserAHarrisRSattarNEbrahimSDavey SmithGLawlorDA. Alanine Aminotransferase, Gamma-Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and Meta-Analysis. Diabetes Care (2009) 32(4):741–50. doi: 10.2337/dc08-1870

  • 69

    RuhlCEEverhartJE. Elevated Serum Alanine Aminotransferase and Gamma-Glutamyltransferase and Mortality in the United States Population. Gastroenterology (2009) 136(2):477–85 e11. doi: 10.1053/j.gastro.2008.10.052

  • 70

    ForbesSGodslandIFTaylor-RobinsonSDBellJDThomasELPatelNet al. A History of Previous Gestational Diabetes Mellitus Is Associated With Adverse Changes in Insulin Secretion and VLDL Metabolism Independently of Increased Intrahepatocellular Lipid. Diabetologia (2013) 56(9):2021–33. doi: 10.1007/s00125-013-2956-3

  • 71

    AjmeraVHGundersonEPVanWagnerLBLewisCECarrJJTerraultNA. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol (2016) 111(5):658–64. doi: 10.1038/ajg.2016.57

  • 72

    MehmoodSMargolisMYeCMaple-BrownLHanleyAJConnellyPWet al. Hepatic Fat and Glucose Tolerance in Women With Recent Gestational Diabetes. BMJ Open Diabetes Res Care (2018) 6(1):e000549. doi: 10.1136/bmjdrc-2018-000549

  • 73

    DonnellySRHinkleSNRawalSGrunnetLGChavarroJEVaagAet al. Prospective Study of Gestational Diabetes and Fatty Liver Scores 9 to 16 Years After Pregnancy. J Diabetes (2019) 11(11):895–905. doi: 10.1111/1753-0407.12934

  • 74

    ForbesSTaylor-RobinsonSDPatelNAllanPWalkerBRJohnstonDG. Increased Prevalence of Non-Alcoholic Fatty Liver Disease in European Women With a History of Gestational Diabetes. Diabetologia (2011) 54(3):641–7. doi: 10.1007/s00125-010-2009-0

  • 75

    FranzagoMFraticelliFStuppiaLVitacolonnaE. Nutrigenetics, Epigenetics and Gestational Diabetes: Consequences in Mother and Child. Epigenetics (2019) 14(3):215–35. doi: 10.1080/15592294.2019.1582277

  • 76

    AikenCEOzanneSE. Transgenerational Developmental Programming. Hum Reprod Update (2014) 20(1):63–75. doi: 10.1093/humupd/dmt043

  • 77

    DingTTXiangJLuoBRHuJ. Relationship Between the IADPSG-Criteria-Defined Abnormal Glucose Values and Adverse Pregnancy Outcomes Among Women Having Gestational Diabetes Mellitus: A Retrospective Cohort Study. Med (Baltimore) (2018) 97(43):e12920. doi: 10.1097/MD.0000000000012920

  • 78

    WalterETsumiEWainstockTSpiegelESheinerE. Maternal Gestational Diabetes Mellitus: Is It Associated With Long-Term Pediatric Ophthalmic Morbidity of the Offspring? J Matern Fetal Neonatal Med (2019) 32(15):2529–38. doi: 10.1080/14767058.2018.1439918

  • 79

    LiuXLiuGWangPHuangYLiuELiDet al. Prevalence of Congenital Heart Disease and Its Related Risk Indicators Among 90,796 Chinese Infants Aged Less Than 6 Months in Tianjin. Int J Epidemiol (2015) 44(3):884–93. doi: 10.1093/ije/dyv107

  • 80

    XuanDSZhaoXLiuYCXingQNShangHLZhuPYet al. Brain Development in Infants of Mothers With Gestational Diabetes Mellitus: A Diffusion Tensor Imaging Study. J Comput Assist Tomogr (2020) 44(6):947–52. doi: 10.1097/RCT.0000000000001110

  • 81

    KrishnaveniGVVeenaSRJonesASrinivasanKOsmondCKaratSCet al. Exposure to Maternal Gestational Diabetes Is Associated With Higher Cardiovascular Responses to Stress in Adolescent Indians. J Clin Endocrinol Metab (2015) 100(3):986–93. doi: 10.1210/jc.2014-3239

  • 82

    VeenaSRKrishnaveniGVSrinivasanKKurpadAVMuthayyaSHillJCet al. Childhood Cognitive Ability: Relationship to Gestational Diabetes Mellitus in India. Diabetologia (2010) 53(10):2134–8. doi: 10.1007/s00125-010-1847-0

  • 83

    ShorerDTWainstockTSheinerELandauDParienteG. Long-Term Endocrine Outcome of Small for Gestational Age Infants Born to Mothers With and Without Gestational Diabetes Mellitus. Gynecol Endocrinol (2019) 35(11):1003–9. doi: 10.1080/09513590.2019.1616174

  • 84

    DabeleaDCrumeT. Maternal Environment and the Transgenerational Cycle of Obesity and Diabetes. Diabetes (2011) 60(7):1849–55. doi: 10.2337/db11-0400

  • 85

    VenkataramanHRamUCraikSArungunasekaranASeshadriSSaravananP. Increased Fetal Adiposity Prior to Diagnosis of Gestational Diabetes in South Asians: More Evidence for the 'Thin-Fat' Baby. Diabetologia (2017) 60(3):399–405. doi: 10.1007/s00125-016-4166-2

  • 86

    SletnerLJenumAKYajnikCSMorkridKNakstadBRognerud-JensenOHet al. Fetal Growth Trajectories in Pregnancies of European and South Asian Mothers With and Without Gestational Diabetes, a Population-Based Cohort Study. PloS One (2017) 12(3):e0172946. doi: 10.1371/journal.pone.0172946

  • 87

    BowersKLaughonSKKielyMBriteJChenZZhangC. Gestational Diabetes, Pre-Pregnancy Obesity and Pregnancy Weight Gain in Relation to Excess Fetal Growth: Variations by Race/Ethnicity. Diabetologia (2013) 56(6):1263–71. doi: 10.1007/s00125-013-2881-5

  • 88

    MocarskiMSavitzDA. Ethnic Differences in the Association Between Gestational Diabetes and Pregnancy Outcome. Matern Child Health J (2012) 16(2):364–73. doi: 10.1007/s10995-011-0760-6

  • 89

    KosmanMWEskesSAvan SelstJBirnieEvan GemundNKarsdorpVHet al. Perinatal Outcomes in Gestational Diabetes in Relation to Ethnicity in the Netherlands. Neth J Med (2016) 74(1):22–9.

  • 90

    AnandSSGuptaMTeoKKSchulzeKMDesaiDAbdallaNet al. Causes and Consequences of Gestational Diabetes in South Asians Living in Canada: Results From a Prospective Cohort Study. CMAJ Open (2017) 5(3):E604–E11. doi: 10.9778/cmajo.20170027

  • 91

    RenkemaKYVerhaarMCKnoersNV. Diabetes-Induced Congenital Anomalies of the Kidney and Urinary Tract (CAKUT): Nurture and Nature at Work? Am J Kidney Dis (2015) 65(5):644–6. doi: 10.1053/j.ajkd.2015.02.320

  • 92

    WuYLiuBSunYDuYSantillanMKSantillanDAet al. Association of Maternal Prepregnancy Diabetes and Gestational Diabetes Mellitus With Congenital Anomalies of the Newborn. Diabetes Care (2020) 43(12):2983–90. doi: 10.2337/dc20-0261

  • 93

    HoodbhoyZMohammedNAslamNFatimaUAshiqaliSRizviAet al. Is the Child at Risk? Cardiovascular Remodelling in Children Born to Diabetic Mothers. Cardiol Young (2019) 29(4):467–74. doi: 10.1017/S1047951119000040

  • 94

    WestJSantorelliGWhincupPHSmithLSattarNACameronNet al. Association of Maternal Exposures With Adiposity at Age 4/5 Years in White British and Pakistani Children: Findings From the Born in Bradford Study. Diabetologia (2018) 61(1):242–52. doi: 10.1007/s00125-017-4457-2

  • 95

    FairleyLSantorelliGLawlorDABryantMBhopalRPetherickESet al. The Relationship Between Early Life Modifiable Risk Factors for Childhood Obesity, Ethnicity and Body Mass Index at Age 3 Years: Findings From the Born in Bradford Birth Cohort Study. BMC Obes (2015) 2:9. doi: 10.1186/s40608-015-0037-5

  • 96

    FaithMSHittnerJBHurstonSRYinJGreenspanLCQuesenberryCPJr.et al. Association of Infant Temperament With Subsequent Obesity in Young Children of Mothers With Gestational Diabetes Mellitus. JAMA Pediatr (2019) 173(5):424–33. doi: 10.1001/jamapediatrics.2018.5199

  • 97

    AndersonJLWallerDKCanfieldMAShawGMWatkinsMLWerlerMM. Maternal Obesity, Gestational Diabetes, and Central Nervous System Birth Defects. Epidemiology (2005) 16(1):87–92. doi: 10.1097/01.ede.0000147122.97061.bb

  • 98

    SahariahSAPotdarRDGandhiMKehoeSHBrownNSaneHet al. A Daily Snack Containing Leafy Green Vegetables, Fruit, and Milk Before and During Pregnancy Prevents Gestational Diabetes in a Randomized, Controlled Trial in Mumbai, India. J Nutr (2016) 146(7):1453S–60S. doi: 10.3945/jn.115.223461

  • 99

    NgaHTQuyenPNChaffeeBWDiep AnhNTNguTKingJC. Effect of a Nutrient-Rich, Food-Based Supplement Given to Rural Vietnamese Mothers Prior to and/or During Pregnancy on Birth Outcomes: A Randomized Controlled Trial. PloS One (2020) 15(5):e0232197. doi: 10.1371/journal.pone.0232197

  • 100

    GuoJTangYWileyJWhittemoreRChenJL. Effectiveness of a Diabetes Prevention Program for Rural Women With Prior Gestational Diabetes Mellitus: Study Protocol of a Multi-Site Randomized Clinical Trial. BMC Public Health (2018) 18(1):809. doi: 10.1186/s12889-018-5725-x

  • 101

    BuchananTAXiangAHPetersRKKjosSLMarroquinAGoicoJet al. Preservation of Pancreatic Beta-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women. Diabetes (2002) 51(9):2796–803. doi: 10.2337/diabetes.51.9.2796

  • 102

    XiangAHPetersRKKjosSLMarroquinAGoicoJOchoaCet al. Effect of Pioglitazone on Pancreatic Beta-Cell Function and Diabetes Risk in Hispanic Women With Prior Gestational Diabetes. Diabetes (2006) 55(2):517–22. doi: 10.2337/diabetes.55.02.06.db05-1066

  • 103

    KnowlerWCBarrett-ConnorEFowlerSEHammanRFLachinJMWalkerEAet al. Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin. N Engl J Med (2002) 346(6):393–403. doi: 10.1056/NEJMoa012512

  • 104

    LiuHWangLZhangSLengJLiNLiWet al. One-Year Weight Losses in the Tianjin Gestational Diabetes Mellitus Prevention Programme: A Randomized Clinical Trial. Diabetes Obes Metab (2018) 20(5):1246–55. doi: 10.1111/dom.13225

  • 105

    LimKChiCChanSYLimSLAngSMYoongJSet al. Smart Phone APP to Restore Optimal Weight (SPAROW): Protocol for a Randomised Controlled Trial for Women With Recent Gestational Diabetes. BMC Public Health (2019) 19(1):1287. doi: 10.1186/s12889-019-7691-3

  • 106

    ShyamSArshadFAbdul GhaniRWahabNASafiiNSNisakMYet al. Low Glycaemic Index Diets Improve Glucose Tolerance and Body Weight in Women With Previous History of Gestational Diabetes: A Six Months Randomized Trial. Nutr J (2013) 12:68. doi: 10.1186/1475-2891-12-68

  • 107

    GuptaYKapoorDJosyulaLKPraveenDNaheedADesaiAKet al. A Lifestyle Intervention Programme for the Prevention of Type 2 Diabetes Mellitus Among South Asian Women With Gestational Diabetes Mellitus [LIVING Study]: Protocol for a Randomized Trial. Diabetes Med (2019) 36(2):243–51. doi: 10.1111/dme.13850

  • 108

    TheL. Taking Urgent Action on Health Inequities. Lancet (2020) 395(10225):659. doi: 10.1016/S0140-6736(20)30455-4

  • 109

    WatkinsonRESuttonMTurnerAJ. Ethnic Inequalities in Health-Related Quality of Life Among Older Adults in England: Secondary Analysis of a National Cross-Sectional Survey. Lancet Public Health (2021) 6(3):e145–54. doi: 10.1016/S2468-2667(20)30287-5

  • 110

    McIntyreHDKapurADivakarHHodM. Gestational Diabetes Mellitus-Innovative Approach to Prediction, Diagnosis, Management, and Prevention of Future NCD-Mother and Offspring. Front Endocrinol (Lausanne) (2020) 11:614533. doi: 10.3389/fendo.2020.614533

Summary

Keywords

gestational diabetes mellitus, Asians, prevalence, diagnostic criteria, diagnostic guidelines, maternal health outcomes, offspring health outcomes

Citation

Li L-J, Huang L, Tobias DK and Zhang C (2022) Gestational Diabetes Mellitus Among Asians – A Systematic Review From a Population Health Perspective. Front. Endocrinol. 13:840331. doi: 10.3389/fendo.2022.840331

Received

21 December 2021

Accepted

11 April 2022

Published

16 June 2022

Volume

13 - 2022

Edited by

Xiongfei Pan, West China Second University Hospital, Sichuan University, China

Reviewed by

Tai-Ho Hung, Taipei Chang Gung Memorial Hospital, Taiwan; Yeyi Zhu, Kaiser Permanente, United States

Updates

Copyright

*Correspondence: Ling-Jun Li, ; Cuilin Zhang,

This article was submitted to Developmental Endocrinology, a section of the journal Frontiers in Endocrinology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics